| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | protein phosphatase activator activity | 1.23e-08 | 17 | 94 | 5 | GO:0072542 | |
| GeneOntologyMolecularFunction | phosphatase activator activity | 3.04e-08 | 20 | 94 | 5 | GO:0019211 | |
| GeneOntologyMolecularFunction | adenylate cyclase activator activity | 1.00e-06 | 5 | 94 | 3 | GO:0010856 | |
| GeneOntologyMolecularFunction | phosphatase regulator activity | 1.05e-06 | 113 | 94 | 7 | GO:0019208 | |
| GeneOntologyMolecularFunction | type 3 metabotropic glutamate receptor binding | 2.00e-06 | 6 | 94 | 3 | GO:0031800 | |
| GeneOntologyMolecularFunction | protein phosphatase regulator activity | 7.73e-06 | 100 | 94 | 6 | GO:0019888 | |
| GeneOntologyMolecularFunction | adenylate cyclase regulator activity | 8.31e-06 | 9 | 94 | 3 | GO:0010854 | |
| GeneOntologyMolecularFunction | nitric-oxide synthase regulator activity | 1.18e-05 | 10 | 94 | 3 | GO:0030235 | |
| GeneOntologyMolecularFunction | cyclase activator activity | 2.79e-05 | 13 | 94 | 3 | GO:0010853 | |
| GeneOntologyMolecularFunction | titin binding | 3.54e-05 | 14 | 94 | 3 | GO:0031432 | |
| GeneOntologyMolecularFunction | G protein-coupled glutamate receptor binding | 5.41e-05 | 16 | 94 | 3 | GO:0035256 | |
| GeneOntologyMolecularFunction | adenylate cyclase binding | 5.41e-05 | 16 | 94 | 3 | GO:0008179 | |
| GeneOntologyMolecularFunction | cyclase regulator activity | 7.83e-05 | 18 | 94 | 3 | GO:0010851 | |
| GeneOntologyMolecularFunction | nitric-oxide synthase binding | 1.46e-04 | 22 | 94 | 3 | GO:0050998 | |
| GeneOntologyMolecularFunction | transmembrane transporter binding | 1.63e-04 | 172 | 94 | 6 | GO:0044325 | |
| GeneOntologyMolecularFunction | protein serine/threonine kinase activator activity | 5.03e-04 | 78 | 94 | 4 | GO:0043539 | |
| GeneOntologyMolecularFunction | ion channel regulator activity | 1.01e-03 | 162 | 94 | 5 | GO:0099106 | |
| GeneOntologyMolecularFunction | phosphatidylinositol 3-kinase binding | 1.09e-03 | 43 | 94 | 3 | GO:0043548 | |
| GeneOntologyMolecularFunction | calcium-dependent protein binding | 1.19e-03 | 98 | 94 | 4 | GO:0048306 | |
| GeneOntologyMolecularFunction | channel regulator activity | 1.39e-03 | 174 | 94 | 5 | GO:0016247 | |
| GeneOntologyMolecularFunction | transporter regulator activity | 1.50e-03 | 177 | 94 | 5 | GO:0141108 | |
| GeneOntologyMolecularFunction | histone binding | 1.59e-03 | 265 | 94 | 6 | GO:0042393 | |
| GeneOntologyMolecularFunction | calcium channel inhibitor activity | 1.65e-03 | 13 | 94 | 2 | GO:0019855 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic ion channel activity | 1.70e-03 | 182 | 94 | 5 | GO:0005244 | |
| GeneOntologyMolecularFunction | voltage-gated channel activity | 1.78e-03 | 184 | 94 | 5 | GO:0022832 | |
| GeneOntologyMolecularFunction | histone acetyltransferase activity | 1.79e-03 | 51 | 94 | 3 | GO:0004402 | |
| GeneOntologyMolecularFunction | peptide-lysine-N-acetyltransferase activity | 2.22e-03 | 55 | 94 | 3 | GO:0061733 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | 2.42e-03 | 614 | 94 | 9 | GO:0140657 | |
| GeneOntologyMolecularFunction | potassium channel regulator activity | 2.46e-03 | 57 | 94 | 3 | GO:0015459 | |
| GeneOntologyMolecularFunction | peptide N-acetyltransferase activity | 2.85e-03 | 60 | 94 | 3 | GO:0034212 | |
| GeneOntologyMolecularFunction | modification-dependent protein binding | 2.91e-03 | 206 | 94 | 5 | GO:0140030 | |
| GeneOntologyMolecularFunction | enzyme activator activity | 3.75e-03 | 656 | 94 | 9 | GO:0008047 | |
| GeneOntologyBiologicalProcess | regulation of cation channel activity | 1.49e-08 | 138 | 95 | 9 | GO:2001257 | |
| GeneOntologyBiologicalProcess | positive regulation of calcium ion transmembrane transporter activity | 2.35e-08 | 39 | 95 | 6 | GO:1901021 | |
| GeneOntologyBiologicalProcess | positive regulation of cyclic-nucleotide phosphodiesterase activity | 9.47e-08 | 3 | 95 | 3 | GO:0051343 | |
| GeneOntologyBiologicalProcess | positive regulation of cation channel activity | 2.19e-07 | 56 | 95 | 6 | GO:2001259 | |
| GeneOntologyBiologicalProcess | regulation of monoatomic ion transmembrane transporter activity | 2.92e-07 | 256 | 95 | 10 | GO:0032412 | |
| GeneOntologyBiologicalProcess | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum | 3.99e-07 | 33 | 95 | 5 | GO:0010880 | |
| GeneOntologyBiologicalProcess | regulation of transmembrane transporter activity | 4.15e-07 | 266 | 95 | 10 | GO:0022898 | |
| GeneOntologyBiologicalProcess | release of sequestered calcium ion into cytosol by sarcoplasmic reticulum | 7.23e-07 | 37 | 95 | 5 | GO:0014808 | |
| GeneOntologyBiologicalProcess | negative regulation of calcium ion export across plasma membrane | 9.40e-07 | 5 | 95 | 3 | GO:1905913 | |
| GeneOntologyBiologicalProcess | release of sequestered calcium ion into cytosol by endoplasmic reticulum | 9.48e-07 | 39 | 95 | 5 | GO:1903514 | |
| GeneOntologyBiologicalProcess | regulation of transporter activity | 1.20e-06 | 299 | 95 | 10 | GO:0032409 | |
| GeneOntologyBiologicalProcess | regulation of monoatomic cation transmembrane transport | ANK2 CALM1 CALM2 CALM3 ABCC9 CASQ1 KCNG1 ANO6 ASPH UTRN CRBN | 1.41e-06 | 380 | 95 | 11 | GO:1904062 |
| GeneOntologyBiologicalProcess | sarcoplasmic reticulum calcium ion transport | 1.76e-06 | 44 | 95 | 5 | GO:0070296 | |
| GeneOntologyBiologicalProcess | regulation of calcium ion export across plasma membrane | 1.87e-06 | 6 | 95 | 3 | GO:1905912 | |
| GeneOntologyBiologicalProcess | regulation of cyclic-nucleotide phosphodiesterase activity | 1.87e-06 | 6 | 95 | 3 | GO:0051342 | |
| GeneOntologyBiologicalProcess | regulation of metal ion transport | CACNA1B ANK2 CALM1 CALM2 CALM3 ABCC9 CASQ1 KCNG1 ANO6 ASPH UTRN CRBN | 2.75e-06 | 493 | 95 | 12 | GO:0010959 |
| GeneOntologyBiologicalProcess | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion | 2.90e-06 | 22 | 95 | 4 | GO:0010881 | |
| GeneOntologyBiologicalProcess | regulation of monoatomic ion transmembrane transport | ANK2 CALM1 CALM2 CALM3 ABCC9 CASQ1 KCNG1 ANO6 ASPH UTRN CRBN | 3.44e-06 | 417 | 95 | 11 | GO:0034765 |
| GeneOntologyBiologicalProcess | regulation of calcium ion transmembrane transporter activity | 4.22e-06 | 92 | 95 | 6 | GO:1901019 | |
| GeneOntologyBiologicalProcess | negative regulation of high voltage-gated calcium channel activity | 5.21e-06 | 8 | 95 | 3 | GO:1901842 | |
| GeneOntologyBiologicalProcess | positive regulation of ion transmembrane transporter activity | 5.74e-06 | 97 | 95 | 6 | GO:0032414 | |
| GeneOntologyBiologicalProcess | regulation of release of sequestered calcium ion into cytosol | 6.09e-06 | 98 | 95 | 6 | GO:0051279 | |
| GeneOntologyBiologicalProcess | positive regulation of ryanodine-sensitive calcium-release channel activity | 7.79e-06 | 9 | 95 | 3 | GO:0060316 | |
| GeneOntologyBiologicalProcess | regulation of cardiac muscle contraction by calcium ion signaling | 7.94e-06 | 28 | 95 | 4 | GO:0010882 | |
| GeneOntologyBiologicalProcess | positive regulation of transporter activity | 1.01e-05 | 107 | 95 | 6 | GO:0032411 | |
| GeneOntologyBiologicalProcess | regulation of cardiac muscle cell action potential | 1.06e-05 | 30 | 95 | 4 | GO:0098901 | |
| GeneOntologyBiologicalProcess | positive regulation of calcium ion transmembrane transport | 1.13e-05 | 109 | 95 | 6 | GO:1904427 | |
| GeneOntologyBiologicalProcess | regulation of striated muscle contraction | 1.25e-05 | 111 | 95 | 6 | GO:0006942 | |
| GeneOntologyBiologicalProcess | regulation of monoatomic ion transport | CACNA1B ANK2 CALM1 CALM2 CALM3 ABCC9 CASQ1 KCNG1 ANO6 ASPH UTRN CRBN | 1.35e-05 | 577 | 95 | 12 | GO:0043269 |
| GeneOntologyBiologicalProcess | negative regulation of ryanodine-sensitive calcium-release channel activity | 1.52e-05 | 11 | 95 | 3 | GO:0060315 | |
| GeneOntologyBiologicalProcess | positive regulation of cation transmembrane transport | 1.59e-05 | 174 | 95 | 7 | GO:1904064 | |
| GeneOntologyBiologicalProcess | calcium ion export across plasma membrane | 2.02e-05 | 12 | 95 | 3 | GO:1990034 | |
| GeneOntologyBiologicalProcess | regulation of cell communication by electrical coupling involved in cardiac conduction | 2.02e-05 | 12 | 95 | 3 | GO:1901844 | |
| GeneOntologyBiologicalProcess | detection of calcium ion | 2.62e-05 | 13 | 95 | 3 | GO:0005513 | |
| GeneOntologyBiologicalProcess | maintenance of location in cell | 2.63e-05 | 259 | 95 | 8 | GO:0051651 | |
| GeneOntologyBiologicalProcess | positive regulation of monoatomic ion transmembrane transport | 3.01e-05 | 192 | 95 | 7 | GO:0034767 | |
| GeneOntologyBiologicalProcess | action potential | 4.03e-05 | 201 | 95 | 7 | GO:0001508 | |
| GeneOntologyBiologicalProcess | regulation of high voltage-gated calcium channel activity | 5.08e-05 | 16 | 95 | 3 | GO:1901841 | |
| GeneOntologyBiologicalProcess | substantia nigra development | 5.44e-05 | 45 | 95 | 4 | GO:0021762 | |
| GeneOntologyBiologicalProcess | regulation of cardiac muscle contraction | 5.70e-05 | 89 | 95 | 5 | GO:0055117 | |
| GeneOntologyBiologicalProcess | release of sequestered calcium ion into cytosol | 5.88e-05 | 146 | 95 | 6 | GO:0051209 | |
| GeneOntologyBiologicalProcess | negative regulation of sequestering of calcium ion | 6.10e-05 | 147 | 95 | 6 | GO:0051283 | |
| GeneOntologyBiologicalProcess | negative regulation of release of sequestered calcium ion into cytosol | 6.14e-05 | 17 | 95 | 3 | GO:0051280 | |
| GeneOntologyBiologicalProcess | calcium ion transmembrane import into cytosol | 6.53e-05 | 217 | 95 | 7 | GO:0097553 | |
| GeneOntologyBiologicalProcess | striated muscle contraction | 6.53e-05 | 217 | 95 | 7 | GO:0006941 | |
| GeneOntologyBiologicalProcess | regulation of sequestering of calcium ion | 6.58e-05 | 149 | 95 | 6 | GO:0051282 | |
| GeneOntologyBiologicalProcess | positive regulation of release of sequestered calcium ion into cytosol | 7.04e-05 | 48 | 95 | 4 | GO:0051281 | |
| GeneOntologyBiologicalProcess | regulation of cell communication by electrical coupling | 7.35e-05 | 18 | 95 | 3 | GO:0010649 | |
| GeneOntologyBiologicalProcess | sequestering of calcium ion | 7.62e-05 | 153 | 95 | 6 | GO:0051208 | |
| GeneOntologyBiologicalProcess | head development | CALM1 CALM2 CALM3 KAT6A AK7 METTL14 ASPH ARL13B MACROD2 TAF1 HERC1 HSPA5 HYDIN SEMA3E | 7.80e-05 | 919 | 95 | 14 | GO:0060322 |
| GeneOntologyBiologicalProcess | positive regulation of calcium ion transport | 7.90e-05 | 154 | 95 | 6 | GO:0051928 | |
| GeneOntologyBiologicalProcess | regulation of transmembrane transport | ANK2 CALM1 CALM2 CALM3 ABCC9 CASQ1 KCNG1 ANO6 ASPH UTRN CRBN | 8.36e-05 | 589 | 95 | 11 | GO:0034762 |
| GeneOntologyBiologicalProcess | midbrain development | 8.60e-05 | 97 | 95 | 5 | GO:0030901 | |
| GeneOntologyBiologicalProcess | regulation of potassium ion transmembrane transport | 8.60e-05 | 97 | 95 | 5 | GO:1901379 | |
| GeneOntologyBiologicalProcess | positive regulation of sequestering of calcium ion | 8.69e-05 | 19 | 95 | 3 | GO:0051284 | |
| GeneOntologyBiologicalProcess | maintenance of location | 8.87e-05 | 396 | 95 | 9 | GO:0051235 | |
| GeneOntologyBiologicalProcess | muscle contraction | 9.58e-05 | 400 | 95 | 9 | GO:0006936 | |
| GeneOntologyBiologicalProcess | cardiac conduction | 9.93e-05 | 100 | 95 | 5 | GO:0061337 | |
| GeneOntologyBiologicalProcess | monoatomic cation transmembrane transport | CACNA1B ANK2 CALM1 CALM2 CALM3 ABCC9 CASQ1 PIEZO2 KCNG1 ANO6 ASPH KCNS3 UTRN CRBN | 1.01e-04 | 942 | 95 | 14 | GO:0098655 |
| GeneOntologyBiologicalProcess | negative regulation of voltage-gated calcium channel activity | 1.19e-04 | 21 | 95 | 3 | GO:1901386 | |
| GeneOntologyBiologicalProcess | cardiac muscle contraction | 1.23e-04 | 167 | 95 | 6 | GO:0060048 | |
| GeneOntologyBiologicalProcess | negative regulation of cation channel activity | 1.29e-04 | 56 | 95 | 4 | GO:2001258 | |
| GeneOntologyBiologicalProcess | regulation of heart contraction | 1.54e-04 | 249 | 95 | 7 | GO:0008016 | |
| GeneOntologyBiologicalProcess | cell communication involved in cardiac conduction | 1.58e-04 | 59 | 95 | 4 | GO:0086065 | |
| GeneOntologyBiologicalProcess | negative regulation of peptidyl-threonine phosphorylation | 1.79e-04 | 24 | 95 | 3 | GO:0010801 | |
| GeneOntologyBiologicalProcess | regulation of heterochromatin formation | 1.79e-04 | 24 | 95 | 3 | GO:0031445 | |
| GeneOntologyBiologicalProcess | regulation of potassium ion transmembrane transporter activity | 2.04e-04 | 63 | 95 | 4 | GO:1901016 | |
| GeneOntologyBiologicalProcess | regulation of ryanodine-sensitive calcium-release channel activity | 2.28e-04 | 26 | 95 | 3 | GO:0060314 | |
| GeneOntologyBiologicalProcess | cell communication by electrical coupling involved in cardiac conduction | 2.28e-04 | 26 | 95 | 3 | GO:0086064 | |
| GeneOntologyBiologicalProcess | positive regulation of monoatomic ion transport | 2.31e-04 | 266 | 95 | 7 | GO:0043270 | |
| GeneOntologyBiologicalProcess | calcium-mediated signaling | 2.31e-04 | 266 | 95 | 7 | GO:0019722 | |
| GeneOntologyBiologicalProcess | regulation of calcium-mediated signaling | 2.43e-04 | 121 | 95 | 5 | GO:0050848 | |
| GeneOntologyBiologicalProcess | regulation of potassium ion transport | 2.43e-04 | 121 | 95 | 5 | GO:0043266 | |
| GeneOntologyBiologicalProcess | positive regulation of transmembrane transport | 2.70e-04 | 273 | 95 | 7 | GO:0034764 | |
| GeneOntologyBiologicalProcess | inorganic cation transmembrane transport | CACNA1B ANK2 CALM1 CALM2 CALM3 ABCC9 CASQ1 KCNG1 ANO6 ASPH KCNS3 UTRN CRBN | 3.06e-04 | 922 | 95 | 13 | GO:0098662 |
| GeneOntologyBiologicalProcess | positive regulation of protein autophosphorylation | 3.17e-04 | 29 | 95 | 3 | GO:0031954 | |
| GeneOntologyBiologicalProcess | neural nucleus development | 3.42e-04 | 72 | 95 | 4 | GO:0048857 | |
| GeneOntologyBiologicalProcess | regulation of muscle contraction | 3.45e-04 | 202 | 95 | 6 | GO:0006937 | |
| GeneOntologyBiologicalProcess | regulation of phosphatase activity | 3.80e-04 | 74 | 95 | 4 | GO:0010921 | |
| GeneOntologyBiologicalProcess | intracellular protein transmembrane transport | 3.87e-04 | 31 | 95 | 3 | GO:0065002 | |
| GeneOntologyBiologicalProcess | positive regulation of phosphatase activity | 3.87e-04 | 31 | 95 | 3 | GO:0010922 | |
| GeneOntologyBiologicalProcess | positive regulation of peptidyl-threonine phosphorylation | 4.26e-04 | 32 | 95 | 3 | GO:0010800 | |
| GeneOntologyBiologicalProcess | calcium ion transmembrane transport | 4.56e-04 | 392 | 95 | 8 | GO:0070588 | |
| GeneOntologyBiologicalProcess | heart contraction | 4.57e-04 | 298 | 95 | 7 | GO:0060047 | |
| GeneOntologyBiologicalProcess | nucleosome organization | 5.08e-04 | 142 | 95 | 5 | GO:0034728 | |
| GeneOntologyBiologicalProcess | regulation of calcium ion transmembrane transport | 5.17e-04 | 218 | 95 | 6 | GO:1903169 | |
| GeneOntologyBiologicalProcess | regulation of action potential | 5.36e-04 | 81 | 95 | 4 | GO:0098900 | |
| GeneOntologyBiologicalProcess | cell communication by electrical coupling | 5.57e-04 | 35 | 95 | 3 | GO:0010644 | |
| GeneOntologyBiologicalProcess | heart process | 5.67e-04 | 309 | 95 | 7 | GO:0003015 | |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | CACNA1B ANK2 CALM1 CALM2 CALM3 ABCC9 CASQ1 PIEZO2 KCNG1 ANO6 ASPH KCNS3 UTRN CRBN | 5.69e-04 | 1115 | 95 | 14 | GO:0034220 |
| GeneOntologyBiologicalProcess | brain development | CALM1 CALM2 CALM3 AK7 METTL14 ARL13B MACROD2 TAF1 HERC1 HSPA5 HYDIN SEMA3E | 5.75e-04 | 859 | 95 | 12 | GO:0007420 |
| GeneOntologyBiologicalProcess | autophagosome membrane docking | 5.77e-04 | 8 | 95 | 2 | GO:0016240 | |
| GeneOntologyBiologicalProcess | positive regulation of store-operated calcium channel activity | 5.77e-04 | 8 | 95 | 2 | GO:1901341 | |
| GeneOntologyBiologicalProcess | protein-DNA complex organization | BDP1 UIMC1 KAT6A CHRAC1 ZNF462 BAZ1A SUPT6H SMARCC2 ANP32E TAF1 TAF5 TASOR L3MBTL3 | 6.53e-04 | 999 | 95 | 13 | GO:0071824 |
| GeneOntologyBiologicalProcess | metal ion transport | CACNA1B ANK2 CALM1 CALM2 CALM3 ABCC9 CASQ1 KCNG1 ANO6 ASPH KCNS3 UTRN CRBN | 6.59e-04 | 1000 | 95 | 13 | GO:0030001 |
| GeneOntologyBiologicalProcess | negative regulation of ion transmembrane transporter activity | 7.02e-04 | 87 | 95 | 4 | GO:0032413 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell action potential | 7.02e-04 | 87 | 95 | 4 | GO:0086001 | |
| GeneOntologyBiologicalProcess | regulation of voltage-gated calcium channel activity | 7.10e-04 | 38 | 95 | 3 | GO:1901385 | |
| GeneOntologyBiologicalProcess | potassium ion transmembrane transport | 7.17e-04 | 232 | 95 | 6 | GO:0071805 | |
| GeneOntologyBiologicalProcess | regulation of calcium ion transport | 7.37e-04 | 323 | 95 | 7 | GO:0051924 | |
| GeneOntologyCellularComponent | potassium channel complex | 1.07e-05 | 104 | 100 | 6 | GO:0034705 | |
| GeneOntologyCellularComponent | myofibril | 5.04e-05 | 273 | 100 | 8 | GO:0030016 | |
| GeneOntologyCellularComponent | voltage-gated potassium channel complex | 7.61e-05 | 91 | 100 | 5 | GO:0008076 | |
| GeneOntologyCellularComponent | contractile muscle fiber | 7.69e-05 | 290 | 100 | 8 | GO:0043292 | |
| GeneOntologyCellularComponent | CHRAC | 1.35e-04 | 4 | 100 | 2 | GO:0008623 | |
| GeneOntologyCellularComponent | cation channel complex | 1.37e-04 | 235 | 100 | 7 | GO:0034703 | |
| GeneOntologyCellularComponent | sarcomere | 1.95e-04 | 249 | 100 | 7 | GO:0030017 | |
| GeneOntologyCellularComponent | myosin filament | 2.26e-04 | 25 | 100 | 3 | GO:0032982 | |
| GeneOntologyCellularComponent | myosin II complex | 3.19e-04 | 28 | 100 | 3 | GO:0016460 | |
| GeneOntologyCellularComponent | protein phosphatase 4 complex | 3.36e-04 | 6 | 100 | 2 | GO:0030289 | |
| GeneOntologyCellularComponent | calcium channel complex | 4.17e-04 | 73 | 100 | 4 | GO:0034704 | |
| GeneOntologyCellularComponent | monoatomic ion channel complex | 4.65e-04 | 378 | 100 | 8 | GO:0034702 | |
| GeneOntologyCellularComponent | axon terminus | 5.21e-04 | 210 | 100 | 6 | GO:0043679 | |
| GeneOntologyCellularComponent | calyx of Held | 6.76e-04 | 36 | 100 | 3 | GO:0044305 | |
| GeneOntologyCellularComponent | nuclear protein-containing complex | UIMC1 SUPT3H PNN POLR2A SNUPN RBM28 CHRAC1 DIS3 PELP1 BAZ1A SUPT6H SMARCC2 ANP32E TAF1 TAF5 HSPA5 | 8.07e-04 | 1377 | 100 | 16 | GO:0140513 |
| GeneOntologyCellularComponent | RNA polymerase II, holoenzyme | 8.82e-04 | 89 | 100 | 4 | GO:0016591 | |
| GeneOntologyCellularComponent | neuron projection terminus | 8.96e-04 | 233 | 100 | 6 | GO:0044306 | |
| GeneOntologyCellularComponent | SWI/SNF superfamily-type complex | 1.17e-03 | 96 | 100 | 4 | GO:0070603 | |
| GeneOntologyCellularComponent | transporter complex | 1.29e-03 | 550 | 100 | 9 | GO:1990351 | |
| GeneOntologyCellularComponent | motile cilium | 1.59e-03 | 355 | 100 | 7 | GO:0031514 | |
| GeneOntologyCellularComponent | ISWI-type complex | 1.99e-03 | 14 | 100 | 2 | GO:0031010 | |
| GeneOntologyCellularComponent | nuclear DNA-directed RNA polymerase complex | 2.13e-03 | 113 | 100 | 4 | GO:0055029 | |
| GeneOntologyCellularComponent | transferase complex | SUPT3H POLR2A KAT6A CHRAC1 PCMTD1 METTL14 PELP1 UBAC1 KLHL42 TAF1 TAF5 CRBN | 2.15e-03 | 963 | 100 | 12 | GO:1990234 |
| GeneOntologyCellularComponent | DNA-directed RNA polymerase complex | 2.34e-03 | 116 | 100 | 4 | GO:0000428 | |
| GeneOntologyCellularComponent | RNA polymerase complex | 2.57e-03 | 119 | 100 | 4 | GO:0030880 | |
| GeneOntologyCellularComponent | myosin complex | 2.84e-03 | 59 | 100 | 3 | GO:0016459 | |
| GeneOntologyCellularComponent | transcription factor TFTC complex | 3.30e-03 | 18 | 100 | 2 | GO:0033276 | |
| GeneOntologyCellularComponent | ATPase complex | 3.44e-03 | 129 | 100 | 4 | GO:1904949 | |
| GeneOntologyCellularComponent | sperm midpiece | 3.58e-03 | 64 | 100 | 3 | GO:0097225 | |
| GeneOntologyCellularComponent | transmembrane transporter complex | 3.62e-03 | 523 | 100 | 8 | GO:1902495 | |
| GeneOntologyCellularComponent | supramolecular fiber | ESPN DLGAP2 ANK2 CALM1 PNN CALM2 CALM3 MYH7B MYO18A ABCC9 CASQ1 COBL MYO18B | 4.05e-03 | 1179 | 100 | 13 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | ESPN DLGAP2 ANK2 CALM1 PNN CALM2 CALM3 MYH7B MYO18A ABCC9 CASQ1 COBL MYO18B | 4.28e-03 | 1187 | 100 | 13 | GO:0099081 |
| GeneOntologyCellularComponent | distal axon | 4.90e-03 | 435 | 100 | 7 | GO:0150034 | |
| HumanPheno | Abnormal cardiac exercise stress test | 1.05e-05 | 19 | 39 | 4 | HP:0500018 | |
| HumanPheno | Torsade de pointes | 3.31e-05 | 25 | 39 | 4 | HP:0001664 | |
| HumanPheno | Polymorphic ventricular tachycardia | 4.80e-05 | 10 | 39 | 3 | HP:0031677 | |
| HumanPheno | 2:1 atrioventricular block | 5.71e-05 | 2 | 39 | 2 | HP:0034305 | |
| HumanPheno | Prolonged QTc interval | 6.07e-05 | 29 | 39 | 4 | HP:0005184 | |
| HumanPheno | Sinus bradycardia | 6.97e-05 | 30 | 39 | 4 | HP:0001688 | |
| HumanPheno | Ventricular fibrillation | 1.03e-04 | 63 | 39 | 5 | HP:0001663 | |
| HumanPheno | Recurrent joint dislocation | 1.43e-04 | 14 | 39 | 3 | HP:0031869 | |
| HumanPheno | Abnormal T-wave | 1.62e-04 | 37 | 39 | 4 | HP:0005135 | |
| HumanPheno | T-wave alternans | 1.71e-04 | 3 | 39 | 2 | HP:0012266 | |
| HumanPheno | Second degree atrioventricular block | 1.77e-04 | 15 | 39 | 3 | HP:0011706 | |
| Domain | SMK-1 | 2.51e-05 | 2 | 94 | 2 | PF04802 | |
| Domain | DUF625 | 2.51e-05 | 2 | 94 | 2 | IPR006887 | |
| Domain | P-loop_NTPase | ABCF1 LONP2 MYH7B MYO18A ABCC9 ZFYVE1 AK7 MDN1 MPP4 ARL13B ABCB11 MYO18B HYDIN CHST3 | 8.43e-05 | 848 | 94 | 14 | IPR027417 |
| Domain | Myosin-like_IQ_dom | 1.13e-04 | 19 | 94 | 3 | IPR027401 | |
| Domain | - | 1.13e-04 | 19 | 94 | 3 | 4.10.270.10 | |
| Domain | - | ABCF1 LONP2 MYO18A ABCC9 ZFYVE1 AK7 MDN1 MPP4 ARL13B ABCB11 HYDIN CHST3 | 3.58e-04 | 746 | 94 | 12 | 3.40.50.300 |
| Domain | LON | 3.71e-04 | 6 | 94 | 2 | SM00464 | |
| Domain | LON_N | 3.71e-04 | 6 | 94 | 2 | PS51787 | |
| Domain | LON_substr-bd_dom | 3.71e-04 | 6 | 94 | 2 | IPR003111 | |
| Domain | LON_substr_bdg | 3.71e-04 | 6 | 94 | 2 | PF02190 | |
| Domain | AAA+_ATPase | 8.04e-04 | 144 | 94 | 5 | IPR003593 | |
| Domain | AAA | 8.04e-04 | 144 | 94 | 5 | SM00382 | |
| Domain | Myosin_head_motor_dom | 9.17e-04 | 38 | 94 | 3 | IPR001609 | |
| Domain | MYOSIN_MOTOR | 9.17e-04 | 38 | 94 | 3 | PS51456 | |
| Domain | Myosin_head | 9.17e-04 | 38 | 94 | 3 | PF00063 | |
| Domain | MYSc | 9.17e-04 | 38 | 94 | 3 | SM00242 | |
| Domain | ABC_transporter_CS | 1.23e-03 | 42 | 94 | 3 | IPR017871 | |
| Domain | NBPF_dom | 1.34e-03 | 11 | 94 | 2 | IPR010630 | |
| Domain | NBPF | 1.34e-03 | 11 | 94 | 2 | PS51316 | |
| Domain | DUF1220 | 1.34e-03 | 11 | 94 | 2 | PF06758 | |
| Domain | ABC_tran | 1.81e-03 | 48 | 94 | 3 | PF00005 | |
| Domain | ABC_TRANSPORTER_2 | 1.81e-03 | 48 | 94 | 3 | PS50893 | |
| Domain | WH1 | 1.89e-03 | 13 | 94 | 2 | PS50229 | |
| Domain | ABC_TRANSPORTER_1 | 1.92e-03 | 49 | 94 | 3 | PS00211 | |
| Domain | ABC_transporter-like | 2.04e-03 | 50 | 94 | 3 | IPR003439 | |
| Domain | WH2 | 2.19e-03 | 14 | 94 | 2 | SM00246 | |
| Domain | ARM-like | 2.43e-03 | 270 | 94 | 6 | IPR011989 | |
| Domain | WH2 | 2.87e-03 | 16 | 94 | 2 | PF02205 | |
| Domain | Channel_four-helix_dom | 2.97e-03 | 57 | 94 | 3 | IPR027359 | |
| Domain | - | 2.97e-03 | 57 | 94 | 3 | 1.20.120.350 | |
| Domain | Myosin_tail_1 | 3.64e-03 | 18 | 94 | 2 | PF01576 | |
| Domain | Myosin_tail | 3.64e-03 | 18 | 94 | 2 | IPR002928 | |
| Domain | PUA-like_domain | 4.05e-03 | 19 | 94 | 2 | IPR015947 | |
| Domain | WH2_dom | 4.95e-03 | 21 | 94 | 2 | IPR003124 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_CAM_VGCC_RYR_SIGNALING_PATHWAY | 2.64e-07 | 11 | 77 | 4 | M47958 | |
| Pathway | REACTOME_ION_HOMEOSTASIS | 4.57e-07 | 54 | 77 | 6 | MM15202 | |
| Pathway | REACTOME_CAMK_IV_MEDIATED_PHOSPHORYLATION_OF_CREB | 1.55e-06 | 5 | 77 | 3 | MM14493 | |
| Pathway | REACTOME_CAM_PDE_1_ACTIVATION | 3.10e-06 | 6 | 77 | 3 | MM14494 | |
| Pathway | REACTOME_ACTIVATION_OF_RAC1_DOWNSTREAM_OF_NMDARS | 3.10e-06 | 6 | 77 | 3 | MM15662 | |
| Pathway | BIOCARTA_CACAM_PATHWAY | 5.40e-06 | 7 | 77 | 3 | MM1357 | |
| Pathway | BIOCARTA_CACAM_PATHWAY | 1.29e-05 | 9 | 77 | 3 | M3412 | |
| Pathway | REACTOME_STIMULI_SENSING_CHANNELS | 1.63e-05 | 99 | 77 | 6 | MM14910 | |
| Pathway | REACTOME_TETRAHYDROBIOPTERIN_BH4_SYNTHESIS_RECYCLING_SALVAGE_AND_REGULATION | 1.83e-05 | 10 | 77 | 3 | MM14570 | |
| Pathway | KEGG_MEDICUS_REFERENCE_LYSOSOMAL_CA2_RELEASE | 1.83e-05 | 10 | 77 | 3 | M47954 | |
| Pathway | REACTOME_CARDIAC_CONDUCTION | 2.05e-05 | 103 | 77 | 6 | MM15196 | |
| Pathway | REACTOME_CALCINEURIN_ACTIVATES_NFAT | 2.51e-05 | 11 | 77 | 3 | MM14810 | |
| Pathway | REACTOME_ENOS_ACTIVATION | 3.33e-05 | 12 | 77 | 3 | MM14817 | |
| Pathway | REACTOME_IONOTROPIC_ACTIVITY_OF_KAINATE_RECEPTORS | 3.33e-05 | 12 | 77 | 3 | MM15142 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_CAM_CN_SIGNALING_PATHWAY | 3.33e-05 | 12 | 77 | 3 | M47956 | |
| Pathway | REACTOME_SODIUM_CALCIUM_EXCHANGERS | 4.31e-05 | 13 | 77 | 3 | MM15078 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_EGFR_TO_PLCG_CAMK_SIGNALING_PATHWAY | 5.46e-05 | 14 | 77 | 3 | M47386 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_PDGFR_TO_PLCG_CAMK_SIGNALING_PATHWAY | 5.46e-05 | 14 | 77 | 3 | M47388 | |
| Pathway | REACTOME_REDUCTION_OF_CYTOSOLIC_CA_LEVELS | 5.46e-05 | 14 | 77 | 3 | MM15052 | |
| Pathway | BIOCARTA_PGC1A_PATHWAY | 5.46e-05 | 14 | 77 | 3 | MM1473 | |
| Pathway | REACTOME_GLYCOGEN_BREAKDOWN_GLYCOGENOLYSIS | 5.46e-05 | 14 | 77 | 3 | MM15391 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_PLCG_CAMK_SIGNALING_PATHWAY | 6.80e-05 | 15 | 77 | 3 | M47385 | |
| Pathway | BIOCARTA_PGC1A_PATHWAY | 6.80e-05 | 15 | 77 | 3 | M15181 | |
| Pathway | REACTOME_POST_NMDA_RECEPTOR_ACTIVATION_EVENTS | 6.80e-05 | 15 | 77 | 3 | MM15103 | |
| Pathway | BIOCARTA_NDKDYNAMIN_PATHWAY | 6.80e-05 | 15 | 77 | 3 | MM1387 | |
| Pathway | REACTOME_METABOLISM_OF_NITRIC_OXIDE_NOS3_ACTIVATION_AND_REGULATION | 6.80e-05 | 15 | 77 | 3 | MM14795 | |
| Pathway | REACTOME_PKA_MEDIATED_PHOSPHORYLATION_OF_CREB | 8.34e-05 | 16 | 77 | 3 | MM14492 | |
| Pathway | BIOCARTA_MEF2D_PATHWAY | 8.34e-05 | 16 | 77 | 3 | MM1483 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_PLCG_CALCINEURIN_SIGNALING_PATHWAY | 8.34e-05 | 16 | 77 | 3 | M47449 | |
| Pathway | BIOCARTA_GCR_PATHWAY | 1.01e-04 | 17 | 77 | 3 | M10066 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PDGF_PDGFR_PLCG_CAMK_SIGNALING_PATHWAY | 1.01e-04 | 17 | 77 | 3 | M47387 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HIV_GP120_TO_CXCR4_GNAQ_PLCB_G_CALCINEURIN | 1.01e-04 | 17 | 77 | 3 | M47560 | |
| Pathway | BIOCARTA_NDKDYNAMIN_PATHWAY | 1.01e-04 | 17 | 77 | 3 | M5940 | |
| Pathway | BIOCARTA_GCR_PATHWAY | 1.01e-04 | 17 | 77 | 3 | MM1372 | |
| Pathway | BIOCARTA_CCR5_PATHWAY | 1.01e-04 | 17 | 77 | 3 | M2349 | |
| Pathway | KEGG_MEDICUS_REFERENCE_BCR_PLCG_CALCINEURIN_SIGNALING_PATHWAY | 1.21e-04 | 18 | 77 | 3 | M47580 | |
| Pathway | BIOCARTA_MEF2D_PATHWAY | 1.21e-04 | 18 | 77 | 3 | M5290 | |
| Pathway | REACTOME_GLYCOGEN_METABOLISM | 1.21e-04 | 18 | 77 | 3 | MM15577 | |
| Pathway | BIOCARTA_CALCINEURIN_PATHWAY | 1.21e-04 | 18 | 77 | 3 | MM1385 | |
| Pathway | BIOCARTA_CALCINEURIN_PATHWAY | 1.21e-04 | 18 | 77 | 3 | M3430 | |
| Pathway | BIOCARTA_CCR5_PATHWAY | 1.43e-04 | 19 | 77 | 3 | MM1453 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HCMV_US28_TO_GNAQ_PLCB_G_CALCINEURIN_SIGNALING_PATHWAY | 1.43e-04 | 19 | 77 | 3 | M47543 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_CAM_CAMK_SIGNALING_PATHWAY | 1.43e-04 | 19 | 77 | 3 | M47957 | |
| Pathway | WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS | 1.50e-04 | 147 | 77 | 6 | MM15854 | |
| Pathway | BIOCARTA_NOS1_PATHWAY | 1.67e-04 | 20 | 77 | 3 | MM1445 | |
| Pathway | WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS | 1.73e-04 | 151 | 77 | 6 | M39329 | |
| Pathway | BIOCARTA_NOS1_PATHWAY | 1.94e-04 | 21 | 77 | 3 | M11650 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CXCR4_GNAQ_PLCB_G_CALCINEURIN_SIGNALING_PATHWAY | 1.94e-04 | 21 | 77 | 3 | M47542 | |
| Pathway | REACTOME_ION_HOMEOSTASIS | 2.12e-04 | 54 | 77 | 4 | M27460 | |
| Pathway | REACTOME_UNBLOCKING_OF_NMDA_RECEPTORS_GLUTAMATE_BINDING_AND_ACTIVATION | 2.24e-04 | 22 | 77 | 3 | MM15104 | |
| Pathway | REACTOME_PROTEIN_METHYLATION | 2.24e-04 | 22 | 77 | 3 | MM15519 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_ATP2B3_TO_ANGIOTENSIN_ALDOSTERONE_SIGNALING_PATHWAY | 2.57e-04 | 23 | 77 | 3 | M47512 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_PAKS | 2.57e-04 | 23 | 77 | 3 | MM15222 | |
| Pathway | REACTOME_MUSCLE_CONTRACTION | 2.80e-04 | 165 | 77 | 6 | MM15026 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_CACNA1D_H_TO_ANGIOTENSIN_ALDOSTERONE_SIGNALING_PATHWAY | 2.92e-04 | 24 | 77 | 3 | M47509 | |
| Pathway | REACTOME_METABOLISM_OF_COFACTORS | 3.31e-04 | 25 | 77 | 3 | MM15574 | |
| Pathway | BIOCARTA_HDAC_PATHWAY | 3.31e-04 | 25 | 77 | 3 | M1547 | |
| Pathway | BIOCARTA_VIP_PATHWAY | 3.31e-04 | 25 | 77 | 3 | MM1441 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_KCNJ5_TO_ANGIOTENSIN_ALDOSTERONE_SIGNALING_PATHWAY | 3.31e-04 | 25 | 77 | 3 | M47510 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_ATP1A1_TO_ANGIOTENSIN_ALDOSTERONE_SIGNALING_PATHWAY | 3.31e-04 | 25 | 77 | 3 | M47511 | |
| Pathway | BIOCARTA_AT1R_PATHWAY | 3.72e-04 | 26 | 77 | 3 | MM1346 | |
| Pathway | BIOCARTA_VIP_PATHWAY | 3.72e-04 | 26 | 77 | 3 | M17941 | |
| Pathway | REACTOME_CA_DEPENDENT_EVENTS | 3.72e-04 | 26 | 77 | 3 | MM14495 | |
| Pathway | BIOCARTA_HDAC_PATHWAY | 3.72e-04 | 26 | 77 | 3 | MM1371 | |
| Pathway | BIOCARTA_PYK2_PATHWAY | 3.72e-04 | 26 | 77 | 3 | MM1431 | |
| Pathway | REACTOME_ION_CHANNEL_TRANSPORT | 3.96e-04 | 176 | 77 | 6 | MM15718 | |
| Pathway | BIOCARTA_AT1R_PATHWAY | 4.17e-04 | 27 | 77 | 3 | M14899 | |
| Pathway | BIOCARTA_PYK2_PATHWAY | 4.17e-04 | 27 | 77 | 3 | M7739 | |
| Pathway | REACTOME_PLATELET_CALCIUM_HOMEOSTASIS | 4.17e-04 | 27 | 77 | 3 | MM15053 | |
| Pathway | REACTOME_SYNTHESIS_OF_IP3_AND_IP4_IN_THE_CYTOSOL | 4.65e-04 | 28 | 77 | 3 | MM14711 | |
| Pathway | BIOCARTA_NO1_PATHWAY | 4.65e-04 | 28 | 77 | 3 | M4383 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ANGIOTENSIN_ALDOSTERONE_SIGNALING_PATHWAY | 4.65e-04 | 28 | 77 | 3 | M47508 | |
| Pathway | REACTOME_NEURONAL_SYSTEM | 4.73e-04 | 335 | 77 | 8 | MM14503 | |
| Pathway | BIOCARTA_BIOPEPTIDES_PATHWAY | 5.17e-04 | 29 | 77 | 3 | MM1356 | |
| Pathway | BIOCARTA_BIOPEPTIDES_PATHWAY | 5.17e-04 | 29 | 77 | 3 | M13494 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_IQGAPS | 5.17e-04 | 29 | 77 | 3 | MM15219 | |
| Pathway | BIOCARTA_GPCR_PATHWAY | 5.17e-04 | 29 | 77 | 3 | MM1495 | |
| Pathway | BIOCARTA_GPCR_PATHWAY | 5.72e-04 | 30 | 77 | 3 | M9664 | |
| Pathway | REACTOME_VEGFR2_MEDIATED_VASCULAR_PERMEABILITY | 5.72e-04 | 30 | 77 | 3 | MM15170 | |
| Pathway | REACTOME_THE_PHOTOTRANSDUCTION_CASCADE | 6.31e-04 | 31 | 77 | 3 | MM14896 | |
| Pathway | BIOCARTA_BCR_PATHWAY | 6.93e-04 | 32 | 77 | 3 | MM1355 | |
| Pathway | REACTOME_ACTIVATION_OF_KAINATE_RECEPTORS_UPON_GLUTAMATE_BINDING | 6.93e-04 | 32 | 77 | 3 | MM15143 | |
| Pathway | BIOCARTA_BCR_PATHWAY | 7.60e-04 | 33 | 77 | 3 | M9494 | |
| Pathway | BIOCARTA_FMLP_PATHWAY | 8.30e-04 | 34 | 77 | 3 | M10287 | |
| Pathway | WP_GLYCOGEN_METABOLISM | 8.30e-04 | 34 | 77 | 3 | MM15985 | |
| Pathway | BIOCARTA_FMLP_PATHWAY | 8.30e-04 | 34 | 77 | 3 | MM1399 | |
| Pathway | REACTOME_RAF_ACTIVATION | 9.04e-04 | 35 | 77 | 3 | MM15271 | |
| Pathway | REACTOME_ACTIVATION_OF_NMDA_RECEPTORS_AND_POSTSYNAPTIC_EVENTS | 9.04e-04 | 35 | 77 | 3 | MM15109 | |
| Pathway | REACTOME_SMOOTH_MUSCLE_CONTRACTION | 9.04e-04 | 35 | 77 | 3 | MM15114 | |
| Pathway | REACTOME_RNA_POLYMERASE_II_PRE_TRANSCRIPTION_EVENTS | 9.96e-04 | 81 | 77 | 4 | M865 | |
| Pathway | REACTOME_RNA_POLYMERASE_II_PRE_TRANSCRIPTION_EVENTS | 1.09e-03 | 83 | 77 | 4 | MM15314 | |
| Pathway | REACTOME_G_PROTEIN_MEDIATED_EVENTS | 1.24e-03 | 39 | 77 | 3 | MM14496 | |
| Pathway | BIOCARTA_FCER1_PATHWAY | 1.24e-03 | 39 | 77 | 3 | MM1397 | |
| Pathway | BIOCARTA_FCER1_PATHWAY | 1.24e-03 | 39 | 77 | 3 | M1908 | |
| Pathway | WP_GLYCOGEN_SYNTHESIS_AND_DEGRADATION | 1.34e-03 | 40 | 77 | 3 | M39595 | |
| Pathway | BIOCARTA_TCR_PATHWAY | 1.54e-03 | 42 | 77 | 3 | MM1504 | |
| Pathway | BIOCARTA_TCR_PATHWAY | 1.77e-03 | 44 | 77 | 3 | M19784 | |
| Pathway | WP_RENINANGIOTENSINALDOSTERONE_SYSTEM_RAAS | 1.77e-03 | 44 | 77 | 3 | M39845 | |
| Pathway | REACTOME_CA2_PATHWAY | 1.89e-03 | 45 | 77 | 3 | MM15040 | |
| Pathway | REACTOME_RAS_PROCESSING | 1.89e-03 | 45 | 77 | 3 | MM15671 | |
| Pubmed | 2.00e-09 | 19 | 100 | 5 | 20301308 | ||
| Pubmed | 3.48e-09 | 21 | 100 | 5 | 16079250 | ||
| Pubmed | 2.31e-08 | 3 | 100 | 3 | 29932249 | ||
| Pubmed | 2.31e-08 | 3 | 100 | 3 | 18370588 | ||
| Pubmed | Structural organization of the human CaMIII calmodulin gene. | 2.31e-08 | 3 | 100 | 3 | 2223880 | |
| Pubmed | Molecular mechanisms of calmodulin's functional versatility. | 2.31e-08 | 3 | 100 | 3 | 9923700 | |
| Pubmed | 2.31e-08 | 3 | 100 | 3 | 9681195 | ||
| Pubmed | Allosteric mechanism of water-channel gating by Ca2+-calmodulin. | 2.31e-08 | 3 | 100 | 3 | 23893133 | |
| Pubmed | 2.31e-08 | 3 | 100 | 3 | 18940602 | ||
| Pubmed | 2.31e-08 | 3 | 100 | 3 | 25268113 | ||
| Pubmed | Expression of HIV-1 envelope glycoprotein alters cellular calmodulin. | 2.31e-08 | 3 | 100 | 3 | 8573130 | |
| Pubmed | 2.31e-08 | 3 | 100 | 3 | 19651602 | ||
| Pubmed | 2.31e-08 | 3 | 100 | 3 | 10899953 | ||
| Pubmed | 2.31e-08 | 3 | 100 | 3 | 26969752 | ||
| Pubmed | 2.31e-08 | 3 | 100 | 3 | 8314583 | ||
| Pubmed | Structural basis for the activation of anthrax adenylyl cyclase exotoxin by calmodulin. | 2.31e-08 | 3 | 100 | 3 | 11807546 | |
| Pubmed | Fluorescent indicators for Ca2+ based on green fluorescent proteins and calmodulin. | 2.31e-08 | 3 | 100 | 3 | 9278050 | |
| Pubmed | 2.31e-08 | 3 | 100 | 3 | 15719022 | ||
| Pubmed | 2.31e-08 | 3 | 100 | 3 | 8312049 | ||
| Pubmed | Nef of HIV-1 interacts directly with calcium-bound calmodulin. | 2.31e-08 | 3 | 100 | 3 | 11847276 | |
| Pubmed | 2.31e-08 | 3 | 100 | 3 | 10416864 | ||
| Pubmed | 2.31e-08 | 3 | 100 | 3 | 7828884 | ||
| Pubmed | 2.31e-08 | 3 | 100 | 3 | 8862395 | ||
| Pubmed | 2.31e-08 | 3 | 100 | 3 | 37380439 | ||
| Pubmed | 2.31e-08 | 3 | 100 | 3 | 31628181 | ||
| Pubmed | Sequence homology of the 3'-untranslated region of calmodulin III in mammals. | 2.31e-08 | 3 | 100 | 3 | 11710561 | |
| Pubmed | 2.31e-08 | 3 | 100 | 3 | 2445749 | ||
| Pubmed | Signal peptide fragments of preprolactin and HIV-1 p-gp160 interact with calmodulin. | 2.31e-08 | 3 | 100 | 3 | 9362478 | |
| Pubmed | The abundance of calmodulin mRNAs is regulated in phosphorylase kinase-deficient skeletal muscle. | 2.31e-08 | 3 | 100 | 3 | 3384819 | |
| Pubmed | Calmodulin is required for cell-cycle progression during G1 and mitosis. | 2.31e-08 | 3 | 100 | 3 | 2469574 | |
| Pubmed | 2.31e-08 | 3 | 100 | 3 | 21799007 | ||
| Pubmed | Myristoyl moiety of HIV Nef is involved in regulation of the interaction with calmodulin in vivo. | 2.31e-08 | 3 | 100 | 3 | 15632291 | |
| Pubmed | Binding of calmodulin to the HIV-1 matrix protein triggers myristate exposure. | 2.31e-08 | 3 | 100 | 3 | 20956522 | |
| Pubmed | Noncanonical binding of calmodulin to aquaporin-0: implications for channel regulation. | 2.31e-08 | 3 | 100 | 3 | 18786401 | |
| Pubmed | 2.31e-08 | 3 | 100 | 3 | 11072229 | ||
| Pubmed | Blocking the Ca2+-induced conformational transitions in calmodulin with disulfide bonds. | 2.31e-08 | 3 | 100 | 3 | 8631777 | |
| Pubmed | 2.31e-08 | 3 | 100 | 3 | 18553937 | ||
| Pubmed | 2.31e-08 | 3 | 100 | 3 | 16229872 | ||
| Pubmed | 2.31e-08 | 3 | 100 | 3 | 14978283 | ||
| Pubmed | 2.31e-08 | 3 | 100 | 3 | 15063758 | ||
| Pubmed | Calmodulin and HIV type 1: interactions with Gag and Gag products. | 2.31e-08 | 3 | 100 | 3 | 11054265 | |
| Pubmed | 2.31e-08 | 3 | 100 | 3 | 33191766 | ||
| Pubmed | 2.31e-08 | 3 | 100 | 3 | 8226798 | ||
| Pubmed | 2.31e-08 | 3 | 100 | 3 | 9658102 | ||
| Pubmed | The ankyrin repeats of TRPV1 bind multiple ligands and modulate channel sensitivity. | 2.31e-08 | 3 | 100 | 3 | 17582331 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | UIMC1 SUPT3H CALM1 PNN POLR2A RBM28 CHRAC1 RBM25 MDN1 PELP1 BAZ1A SUPT6H ASPH TAF5 TASOR L3MBTL3 HSPA5 JRKL | 2.83e-08 | 1294 | 100 | 18 | 30804502 |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | ABCF1 IPO8 PNN HACD3 KAT6A MYO18A RBM28 CDCA8 MDN1 PELP1 BAZ1A ASPH TASOR L3MBTL3 | 3.86e-08 | 759 | 100 | 14 | 35915203 |
| Pubmed | Endogenous calmodulin interacts with the epidermal growth factor receptor in living cells. | 9.21e-08 | 4 | 100 | 3 | 14960328 | |
| Pubmed | 9.21e-08 | 4 | 100 | 3 | 22405011 | ||
| Pubmed | A calmodulin-binding sequence in the C-terminus of human cardiac titin kinase. | 9.21e-08 | 4 | 100 | 3 | 7607248 | |
| Pubmed | 9.21e-08 | 4 | 100 | 3 | 27516456 | ||
| Pubmed | 9.21e-08 | 4 | 100 | 3 | 11736632 | ||
| Pubmed | Activation mechanism of a human SK-calmodulin channel complex elucidated by cryo-EM structures. | 9.21e-08 | 4 | 100 | 3 | 29724949 | |
| Pubmed | A calcium sensor in the sodium channel modulates cardiac excitability. | 9.21e-08 | 4 | 100 | 3 | 11807557 | |
| Pubmed | 9.21e-08 | 4 | 100 | 3 | 11286509 | ||
| Pubmed | 9.21e-08 | 4 | 100 | 3 | 20953164 | ||
| Pubmed | 9.21e-08 | 4 | 100 | 3 | 30842726 | ||
| Pubmed | Mutations in calmodulin cause ventricular tachycardia and sudden cardiac death. | 9.21e-08 | 4 | 100 | 3 | 23040497 | |
| Pubmed | 9.21e-08 | 4 | 100 | 3 | 19855925 | ||
| Pubmed | 9.21e-08 | 4 | 100 | 3 | 16299511 | ||
| Pubmed | Calmodulin binding to the Fas death domain. Regulation by Fas activation. | 9.21e-08 | 4 | 100 | 3 | 14594800 | |
| Pubmed | Structure of calmodulin bound to the hydrophobic IQ domain of the cardiac Ca(v)1.2 calcium channel. | 9.21e-08 | 4 | 100 | 3 | 16338416 | |
| Pubmed | Role of calmodulin in HIV-potentiated Fas-mediated apoptosis. | 9.21e-08 | 4 | 100 | 3 | 8780394 | |
| Pubmed | 9.21e-08 | 4 | 100 | 3 | 19279214 | ||
| Pubmed | 9.21e-08 | 4 | 100 | 3 | 25437912 | ||
| Pubmed | 9.21e-08 | 4 | 100 | 3 | 17046994 | ||
| Pubmed | A network of control mediated by regulator of calcium/calmodulin-dependent signaling. | 9.21e-08 | 4 | 100 | 3 | 15499021 | |
| Pubmed | 9.21e-08 | 4 | 100 | 3 | 10692436 | ||
| Pubmed | Requirement of calmodulin binding by HIV-1 gp160 for enhanced FAS-mediated apoptosis. | 9.21e-08 | 4 | 100 | 3 | 10625668 | |
| Pubmed | Molecular basis of the death-associated protein kinase-calcium/calmodulin regulator complex. | 9.21e-08 | 4 | 100 | 3 | 20103772 | |
| Pubmed | 9.21e-08 | 4 | 100 | 3 | 16478480 | ||
| Pubmed | 9.21e-08 | 4 | 100 | 3 | 21167176 | ||
| Pubmed | Calcium/calmodulin regulates ubiquitination of the ubiquitin-specific protease TRE17/USP6. | 9.21e-08 | 4 | 100 | 3 | 16127172 | |
| Pubmed | 9.21e-08 | 4 | 100 | 3 | 9096366 | ||
| Pubmed | 9.21e-08 | 4 | 100 | 3 | 12577052 | ||
| Pubmed | 9.21e-08 | 4 | 100 | 3 | 20226167 | ||
| Pubmed | FRET detection of calmodulin binding to the cardiac RyR2 calcium release channel. | 9.21e-08 | 4 | 100 | 3 | 22067155 | |
| Pubmed | 9.21e-08 | 4 | 100 | 3 | 25441029 | ||
| Pubmed | 9.21e-08 | 4 | 100 | 3 | 10823944 | ||
| Pubmed | 9.21e-08 | 4 | 100 | 3 | 16505387 | ||
| Pubmed | 9.21e-08 | 4 | 100 | 3 | 26164367 | ||
| Pubmed | Calm1 signaling pathway is essential for the migration of mouse precerebellar neurons. | 9.21e-08 | 4 | 100 | 3 | 25519244 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | UIMC1 PNN HACD3 POLR2A RBM28 CDCA8 RBM25 PELP1 SLC4A1AP BAZ1A SMARCC2 TAF1 TASOR L3MBTL3 HSPA5 | 9.70e-08 | 954 | 100 | 15 | 36373674 |
| Pubmed | Proteomic analysis of steady-state nuclear hormone receptor coactivator complexes. | 1.77e-07 | 85 | 100 | 6 | 16051665 | |
| Pubmed | 2.30e-07 | 5 | 100 | 3 | 27165696 | ||
| Pubmed | 2.30e-07 | 5 | 100 | 3 | 15140941 | ||
| Pubmed | 2.30e-07 | 5 | 100 | 3 | 11981030 | ||
| Pubmed | 2.30e-07 | 5 | 100 | 3 | 12034722 | ||
| Pubmed | Rab3B in human platelet is membrane bound and interacts with Ca(2+)/calmodulin. | 2.30e-07 | 5 | 100 | 3 | 11741295 | |
| Pubmed | 2.30e-07 | 5 | 100 | 3 | 32522888 | ||
| Pubmed | Inhibition of human ether à go-go potassium channels by Ca(2+)/calmodulin. | 2.30e-07 | 5 | 100 | 3 | 10880439 | |
| Pubmed | Interactions between calmodulin, adenosine A2A, and dopamine D2 receptors. | 2.30e-07 | 5 | 100 | 3 | 19632986 | |
| Pubmed | 2.30e-07 | 5 | 100 | 3 | 3111527 | ||
| Pubmed | 2.30e-07 | 5 | 100 | 3 | 17719545 | ||
| Pubmed | 2.30e-07 | 5 | 100 | 3 | 25703379 | ||
| Pubmed | 2.30e-07 | 5 | 100 | 3 | 35568036 | ||
| Pubmed | 2.30e-07 | 5 | 100 | 3 | 18570893 | ||
| Pubmed | 2.30e-07 | 5 | 100 | 3 | 9242710 | ||
| Pubmed | 2.30e-07 | 5 | 100 | 3 | 25232683 | ||
| Pubmed | Current inhibition of human EAG1 potassium channels by the Ca2+ binding protein S100B. | 2.30e-07 | 5 | 100 | 3 | 20708613 | |
| Interaction | OBSL1 interactions | CACNA1B ABCF1 CALM1 PNN HACD3 CALM3 POLR2A RBM28 CDCA8 PPP4R3A RBM25 MDN1 PELP1 SUPT6H ASPH SMARCC2 UTRN HSPA5 | 3.60e-07 | 902 | 99 | 18 | int:OBSL1 |
| Interaction | SPATA17 interactions | 3.97e-06 | 7 | 99 | 3 | int:SPATA17 | |
| Interaction | HECTD1 interactions | ABCF1 IPO8 PNN HACD3 KAT6A MYO18A RBM28 CDCA8 RBM25 MDN1 PELP1 BAZ1A ASPH TAF1 TASOR L3MBTL3 UTRN | 5.58e-06 | 984 | 99 | 17 | int:HECTD1 |
| Interaction | KCNN1 interactions | 6.33e-06 | 8 | 99 | 3 | int:KCNN1 | |
| Interaction | ARPP21 interactions | 6.33e-06 | 8 | 99 | 3 | int:ARPP21 | |
| Interaction | H2AX interactions | UIMC1 MASP1 CALM1 CALM2 POLR2A METTL14 STK4 MDN1 PELP1 BAZ1A SUPT6H SMARCC2 HSPA5 | 6.63e-06 | 593 | 99 | 13 | int:H2AX |
| Interaction | H2BC21 interactions | UIMC1 PNN POLR2A KAT6A CC2D1B CHRAC1 CDCA8 STK4 PELP1 BAZ1A SUPT6H SMARCC2 ANP32E L3MBTL3 | 7.60e-06 | 696 | 99 | 14 | int:H2BC21 |
| Interaction | SNRPB interactions | PNN POLR2A SNUPN PPP4R3A METTL14 RBM25 SLC4A1AP SUPT6H TASOR L3MBTL3 HSPA5 CRBN | 8.72e-06 | 517 | 99 | 12 | int:SNRPB |
| Interaction | ZNF330 interactions | IPO8 RBM28 CDCA8 NBPF19 SLC4A1AP BAZ1A SUPT6H SMARCC2 ANP32E TAF1 L3MBTL3 | 1.21e-05 | 446 | 99 | 11 | int:ZNF330 |
| Interaction | IQCG interactions | 1.35e-05 | 10 | 99 | 3 | int:IQCG | |
| Interaction | MYL6B interactions | 1.54e-05 | 108 | 99 | 6 | int:MYL6B | |
| Interaction | ANPEP interactions | 2.42e-05 | 174 | 99 | 7 | int:ANPEP | |
| Interaction | NSMF interactions | 2.55e-05 | 35 | 99 | 4 | int:NSMF | |
| Interaction | POLR1G interactions | POLR2A KAT6A RBM28 CDCA8 MDN1 PELP1 SLC4A1AP SUPT6H SMARCC2 ANP32E TAF1 | 2.83e-05 | 489 | 99 | 11 | int:POLR1G |
| Interaction | C11orf65 interactions | 3.17e-05 | 13 | 99 | 3 | int:C11orf65 | |
| Interaction | H3C1 interactions | UIMC1 ANK2 POLR2A KAT6A MYO18A RBM28 CDCA8 PIEZO2 PELP1 BAZ1A SMARCC2 ANP32E TAF1 TAF5 L3MBTL3 | 3.26e-05 | 901 | 99 | 15 | int:H3C1 |
| Interaction | TRDN interactions | 3.40e-05 | 75 | 99 | 5 | int:TRDN | |
| Interaction | KCNQ2 interactions | 5.87e-05 | 84 | 99 | 5 | int:KCNQ2 | |
| Interaction | ZNF280A interactions | 6.15e-05 | 16 | 99 | 3 | int:ZNF280A | |
| Interaction | POLR1D interactions | 6.93e-05 | 141 | 99 | 6 | int:POLR1D | |
| Interaction | UBE3B interactions | 8.31e-05 | 47 | 99 | 4 | int:UBE3B | |
| Interaction | CAMTA2 interactions | 8.89e-05 | 18 | 99 | 3 | int:CAMTA2 | |
| Interaction | FAM120AOS interactions | 1.05e-04 | 19 | 99 | 3 | int:FAM120AOS | |
| Interaction | SMC5 interactions | UIMC1 PNN HACD3 POLR2A RBM28 CDCA8 RBM25 PELP1 SLC4A1AP BAZ1A SMARCC2 TAF1 TASOR L3MBTL3 HSPA5 | 1.06e-04 | 1000 | 99 | 15 | int:SMC5 |
| Interaction | NUCKS1 interactions | 1.07e-04 | 220 | 99 | 7 | int:NUCKS1 | |
| Interaction | UNC13B interactions | 1.24e-04 | 52 | 99 | 4 | int:UNC13B | |
| Interaction | PPEF1 interactions | 1.24e-04 | 52 | 99 | 4 | int:PPEF1 | |
| Interaction | POLR3H interactions | 1.28e-04 | 99 | 99 | 5 | int:POLR3H | |
| Interaction | MEN1 interactions | PNN HACD3 POLR2A RBM28 DIS3 ZNF462 RBM25 MDN1 PELP1 BAZ1A ASPH SMARCC2 COBL TAF1 TASOR | 1.45e-04 | 1029 | 99 | 15 | int:MEN1 |
| Interaction | MYO1C interactions | 1.48e-04 | 397 | 99 | 9 | int:MYO1C | |
| Interaction | MYO6 interactions | 1.51e-04 | 398 | 99 | 9 | int:MYO6 | |
| Interaction | IQGAP1 interactions | NPHS1 CALM1 CALM2 CALM3 MYO18A PEX14 WDFY4 METTL14 GOLIM4 COBL HSPA5 | 1.53e-04 | 591 | 99 | 11 | int:IQGAP1 |
| Interaction | ANKS6 interactions | 1.65e-04 | 56 | 99 | 4 | int:ANKS6 | |
| Interaction | MARCKS interactions | CDC42EP4 ANK2 CALM1 CALM2 CALM3 KAT6A MICALL1 SLC4A1AP ANO6 ARL13B UTRN | 1.78e-04 | 601 | 99 | 11 | int:MARCKS |
| Interaction | TAF10 interactions | 1.85e-04 | 107 | 99 | 5 | int:TAF10 | |
| Interaction | PCNT interactions | 1.88e-04 | 241 | 99 | 7 | int:PCNT | |
| Interaction | LRCH3 interactions | 1.93e-04 | 108 | 99 | 5 | int:LRCH3 | |
| Interaction | IFI16 interactions | ABCF1 IPO8 PNN HACD3 POLR2A RBM28 RBM25 PELP1 SLC4A1AP SMARCC2 TASOR HSPA5 | 1.96e-04 | 714 | 99 | 12 | int:IFI16 |
| Interaction | KIF1B interactions | 2.13e-04 | 173 | 99 | 6 | int:KIF1B | |
| Interaction | PARP1 interactions | UIMC1 PNN HACD3 POLR2A RBM28 CHRAC1 CDCA8 METTL14 MICALL1 ASAP2 RBM25 MDN1 BAZ1A SUPT6H SMARCC2 ANP32E HSPA5 | 2.15e-04 | 1316 | 99 | 17 | int:PARP1 |
| Interaction | SUB1 interactions | 2.18e-04 | 247 | 99 | 7 | int:SUB1 | |
| Interaction | DHX40 interactions | 2.29e-04 | 249 | 99 | 7 | int:DHX40 | |
| Interaction | GSC2 interactions | 2.46e-04 | 62 | 99 | 4 | int:GSC2 | |
| Interaction | PPP4R3A interactions | 2.55e-04 | 179 | 99 | 6 | int:PPP4R3A | |
| Interaction | PHKB interactions | 2.61e-04 | 63 | 99 | 4 | int:PHKB | |
| Interaction | CPSF6 interactions | PNN POLR2A WDFY4 PPP4R3A METTL14 RBM25 SUPT6H UBAC1 SMARCC2 TASOR | 2.62e-04 | 526 | 99 | 10 | int:CPSF6 |
| Interaction | MYL6 interactions | 2.65e-04 | 255 | 99 | 7 | int:MYL6 | |
| Interaction | SNRPB2 interactions | 2.65e-04 | 255 | 99 | 7 | int:SNRPB2 | |
| Interaction | GRK5 interactions | 2.79e-04 | 182 | 99 | 6 | int:GRK5 | |
| Interaction | SIRT7 interactions | ABCF1 PNN POLR2A FRYL RBM28 DIS3 RBM25 MDN1 PELP1 SUPT6H SMARCC2 UTRN | 2.86e-04 | 744 | 99 | 12 | int:SIRT7 |
| Interaction | SNRNP40 interactions | ESPN PNN KAT6A RBM28 ZNF462 RBM25 PELP1 SLC4A1AP SUPT6H SMARCC2 TASOR | 2.93e-04 | 637 | 99 | 11 | int:SNRNP40 |
| Interaction | TBC1D1 interactions | 2.95e-04 | 65 | 99 | 4 | int:TBC1D1 | |
| Interaction | NAA40 interactions | UIMC1 ABCF1 ANK2 CALM1 PNN POLR2A PEX14 DIS3 PPP4R3A STK4 BAZ1A ANP32E TASOR UTRN | 2.97e-04 | 978 | 99 | 14 | int:NAA40 |
| Interaction | FBXO22 interactions | BDP1 ABCF1 POLR2A VPS13D MDN1 SLC4A1AP COBL HERC1 HYDIN RIC1 | 3.23e-04 | 540 | 99 | 10 | int:FBXO22 |
| Interaction | PPP3R1 interactions | 3.71e-04 | 69 | 99 | 4 | int:PPP3R1 | |
| Interaction | CAMKK2 interactions | 3.71e-04 | 69 | 99 | 4 | int:CAMKK2 | |
| Interaction | PHKA2 interactions | 3.71e-04 | 69 | 99 | 4 | int:PHKA2 | |
| Interaction | PPEF2 interactions | 3.83e-04 | 29 | 99 | 3 | int:PPEF2 | |
| Interaction | IQCN interactions | 3.92e-04 | 70 | 99 | 4 | int:IQCN | |
| Interaction | ESCO1 interactions | 4.24e-04 | 30 | 99 | 3 | int:ESCO1 | |
| Interaction | GSK3A interactions | 4.66e-04 | 464 | 99 | 9 | int:GSK3A | |
| Interaction | CETN3 interactions | 4.84e-04 | 74 | 99 | 4 | int:CETN3 | |
| Interaction | PCSK4 interactions | 4.94e-04 | 7 | 99 | 2 | int:PCSK4 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1q21 | 2.66e-04 | 404 | 100 | 6 | chr1q21 | |
| Cytoband | 2p24 | 3.06e-04 | 12 | 100 | 2 | 2p24 | |
| Cytoband | 1q21.2 | 5.15e-04 | 71 | 100 | 3 | 1q21.2 | |
| GeneFamily | Neuroblastoma breakpoint family | 2.23e-08 | 23 | 69 | 5 | 662 | |
| GeneFamily | Myosins, class XVIII | 1.44e-05 | 2 | 69 | 2 | 1107 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 1.88e-03 | 17 | 69 | 2 | 486 | |
| Coexpression | RAMPON_ENRICHED_LEARNING_ENVIRONMENT_EARLY_UP | 4.57e-07 | 17 | 100 | 4 | MM686 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Upper_Layer|World / Primary Cells by Cluster | 3.48e-07 | 200 | 100 | 7 | db10f76938af553d1a2275bb02ef75dff3c3135b | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Upper_Layer-21|World / Primary Cells by Cluster | 3.48e-07 | 200 | 100 | 7 | 30a3e4aee12ec1b5acdce90f86c9733c27a7f6fc | |
| ToppCell | Severe-B_naive-1|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.61e-06 | 159 | 100 | 6 | 2881b054bbeb479221ee3c38bbd9b0815b123579 | |
| ToppCell | Control-B_intermediate-1|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 2.13e-06 | 167 | 100 | 6 | 948504367ecf58144d9dd74d2ec531358fc4b309 | |
| ToppCell | facs-Trachea-nan-18m-Epithelial-ciliated_columnar_cell_of_tracheobronchial_tree|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.89e-06 | 176 | 100 | 6 | ed788a5969edfd1199828ca5b0dd34e7f29c4d30 | |
| ToppCell | facs-Lung-EPCAM-24m-Epithelial-ciliated_columnar_cell_of_tracheobronchial_tree|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.74e-06 | 184 | 100 | 6 | afb11ab301ef9801333dbb53ccff4bd0d44f1677 | |
| ToppCell | facs-Lung-EPCAM-24m-Epithelial-Ciliated_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.74e-06 | 184 | 100 | 6 | a411c0bcb283534a1c15f22473c46b7d87e01294 | |
| ToppCell | facs-Lung-EPCAM-3m-Epithelial-Ciliated_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.10e-06 | 187 | 100 | 6 | 04dba2ed09ee4180830bdf0191921696697ea234 | |
| ToppCell | facs-Lung-EPCAM-3m-Epithelial-ciliated_columnar_cell_of_tracheobronchial_tree|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.10e-06 | 187 | 100 | 6 | 805dafe22f835ece4dd091d8030d0a63b52a48dd | |
| ToppCell | Epithelial-D_(Ciliated)|World / shred on cell class and cell subclass (v4) | 4.36e-06 | 189 | 100 | 6 | 0bf560b595c7a8450a46bc821b742b67965bd9f9 | |
| ToppCell | PBMC-Control-cDC_3|Control / Compartment, Disease Groups and Clusters | 5.37e-06 | 196 | 100 | 6 | 09d197b321ff9f13c0672ea059c850845b0dbbd5 | |
| ToppCell | H1299-infected-SARSCoV2|infected / Cell line, Condition and Strain | 5.53e-06 | 197 | 100 | 6 | 0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 5.86e-06 | 199 | 100 | 6 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | Control-Fibroblasts-Mesothelial_FB|Control / group, cell type (main and fine annotations) | 1.56e-05 | 139 | 100 | 5 | e769beb031b262dd92c9605b07dbf3c29fb82520 | |
| ToppCell | Control-B_intermediate-1|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.85e-05 | 144 | 100 | 5 | 984470ff6ddce4c743e2db78fa98dae055aaa273 | |
| ToppCell | Globus_pallidus-Macroglia-POLYDENDROCYTE-P3-Tnr-Polydendrocyte.Tnr.Cyth3_(Cyth3)-|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 2.47e-05 | 153 | 100 | 5 | 553dff9688a1996d8f4ba16e60c683593d781389 | |
| ToppCell | Globus_pallidus-Macroglia-POLYDENDROCYTE-P3-Tnr-Polydendrocyte.Tnr.Cyth3_(Cyth3)|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 2.47e-05 | 153 | 100 | 5 | 88ca2d2c2ab19fbee13e18951b993ee05dd30f67 | |
| ToppCell | Control-B_naive-1|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 2.63e-05 | 155 | 100 | 5 | 0a78d1cab2bdba2dc8a74cdf35b5a0192370c4b5 | |
| ToppCell | droplet-Thymus-nan-3m-Lymphocytic-DN4|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.76e-05 | 167 | 100 | 5 | 10c9fab3573c2948081aac2cec1798e46e59e38a | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_B-ABC_aged-B_naive|lymph-node_spleen / Manually curated celltypes from each tissue | 3.87e-05 | 168 | 100 | 5 | 494d5a11154ff22fedb25f4036d730cef376da60 | |
| ToppCell | droplet-Thymus-nan-3m-Lymphocytic-DN4_thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.98e-05 | 169 | 100 | 5 | 2de213b083f57f47be58427c0ce127fee9f85caa | |
| ToppCell | PND14-Immune-Immune_Myeloid-DC-cDC2|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.09e-05 | 170 | 100 | 5 | 9e94fa0d05abed3438b28296a293767096d517d6 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Lymphoid-CD4/CD8-CD8_cytotoxic-D|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.70e-05 | 175 | 100 | 5 | a3f8c54c77bce9b035a4835945ab341909be4946 | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.82e-05 | 176 | 100 | 5 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m-Mesenchymal-Ependyma|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.96e-05 | 177 | 100 | 5 | ae01c19403a09f7ba5e4beafdfcd1b8eebdadcb7 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m-Mesenchymal-ependymal_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.96e-05 | 177 | 100 | 5 | bd3d07bdef6e903995d4bbfb6ff3a5e1d9fb70cc | |
| ToppCell | ILEUM-inflamed-(9)_Enteric_neurons|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 5.09e-05 | 178 | 100 | 5 | d9142151819afb0dc22bfb32a9c9dba5f553067d | |
| ToppCell | ILEUM-inflamed-(9)_Neuro_cell|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 5.09e-05 | 178 | 100 | 5 | 611504b0a9e6318b18fba83787b03f9245c82252 | |
| ToppCell | facs-Trachea-18m-Epithelial-airway_epithelial-tracheobronchial_ciliated_cell-ciliated_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.23e-05 | 179 | 100 | 5 | d4efbc34f52136039b96451fd0b0a0ad164197c6 | |
| ToppCell | facs-Trachea-18m-Epithelial-airway_epithelial-tracheobronchial_ciliated_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.23e-05 | 179 | 100 | 5 | 8a66d197a2f55d763ff7ef0bec89ee96f59c3937 | |
| ToppCell | COVID-19_Convalescent|World / Disease condition and Cell class | 5.51e-05 | 181 | 100 | 5 | a62115a8da486fc61225901c72b1ec70bcaf4c36 | |
| ToppCell | wk_15-18-Hematologic-Meg-ery-Definitive_erythroblast|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 5.66e-05 | 182 | 100 | 5 | 93841f730ca1a735eaaf5f2ccbe5c45ab0e029d1 | |
| ToppCell | Adult-Epithelial-ciliated_cell-D122|Adult / Lineage, Cell type, age group and donor | 5.66e-05 | 182 | 100 | 5 | 7ded554a4b441e6496db673ba206c0d76ccad7d9 | |
| ToppCell | droplet-Kidney-nan-21m-Epithelial-Pecam____kidney_capillary_endothelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.80e-05 | 183 | 100 | 5 | f55081068213cc1cdb2acad58ff10f6b48b44c72 | |
| ToppCell | E18.5-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.96e-05 | 184 | 100 | 5 | 797b6a6d6f6aafae98f75ca8bffe8263f8d3ff9b | |
| ToppCell | Children_(3_yrs)-Epithelial-ciliated_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.96e-05 | 184 | 100 | 5 | 5daff849625f2f41d56615569c0ed59cd733b34c | |
| ToppCell | E18.5-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated-Ciliated_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.96e-05 | 184 | 100 | 5 | 77d5b60a20b277f589b18f7a131142a7ef2dac17 | |
| ToppCell | Adult-Epithelial-ciliated_cell-D175|Adult / Lineage, Cell type, age group and donor | 6.11e-05 | 185 | 100 | 5 | 30f4980dee6cd5959655f8d74049f3bfb5312611 | |
| ToppCell | PND14-Epithelial-Epithelial_Airway|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.43e-05 | 187 | 100 | 5 | 1399c703505211c510b3f14c7a2aa9930566c473 | |
| ToppCell | droplet-Lung-LUNG-1m-Epithelial-Ciliated_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.43e-05 | 187 | 100 | 5 | 0334fb1247a5800bf1438a48da8fd905df000d89 | |
| ToppCell | droplet-Lung-LUNG-1m-Epithelial|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.43e-05 | 187 | 100 | 5 | 6288da8cdd450c58df00ebcfcc118f01fab7e610 | |
| ToppCell | droplet-Lung-3m-Epithelial-airway_epithelial-lung_ciliated_cell-ciliated_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.43e-05 | 187 | 100 | 5 | 1bba994aaaa9825b54aaeaff3829850267bc4602 | |
| ToppCell | droplet-Lung-LUNG-1m-Epithelial-ciliated_columnar_cell_of_tracheobronchial_tree|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.43e-05 | 187 | 100 | 5 | cf8e3448402e1d05b8321a5f124bd29e30e18841 | |
| ToppCell | droplet-Lung-3m-Epithelial-airway_epithelial-lung_ciliated_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.43e-05 | 187 | 100 | 5 | d6ac351e7aeba98851d308c14ac395044fe4fbbb | |
| ToppCell | Epithelial-ciliated_cell|World / Lineage, Cell type, age group and donor | 6.59e-05 | 188 | 100 | 5 | 61a459f3fe57e5728efc72637ff2edc2d343492b | |
| ToppCell | droplet-Lung-1m-Epithelial-airway_epithelial-lung_ciliated_cell-ciliated_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.59e-05 | 188 | 100 | 5 | bc0b9ba8ae88e8a89e98b446584ed39606e4229e | |
| ToppCell | Epithelial-Epithelial-D_(Ciliated)|Epithelial / shred on cell class and cell subclass (v4) | 6.59e-05 | 188 | 100 | 5 | 8f30535a32968a81a304315a49c0d90a77d36948 | |
| ToppCell | Adult-Epithelial-ciliated_cell-D231|Adult / Lineage, Cell type, age group and donor | 6.59e-05 | 188 | 100 | 5 | 34b11f72ca73153d02edcd09b38983ad1a504659 | |
| ToppCell | Children_(3_yrs)-Epithelial-ciliated_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.59e-05 | 188 | 100 | 5 | 2b6dfc88be9ded7b88da9fe78a9cd9f9b3af8af3 | |
| ToppCell | droplet-Lung-1m-Epithelial-airway_epithelial|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.59e-05 | 188 | 100 | 5 | 50994e304c719f2f3c3232e48141e2dd15c96612 | |
| ToppCell | droplet-Lung-1m-Epithelial-airway_epithelial-lung_ciliated_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.59e-05 | 188 | 100 | 5 | a7b7ba56603a8a50869b41902aed6a9ab1c5c021 | |
| ToppCell | PND07-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated-Ciliated_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.76e-05 | 189 | 100 | 5 | 057d7a03fdbe779122b203619a6f947f49b84d28 | |
| ToppCell | PND01-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated-Ciliated_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.76e-05 | 189 | 100 | 5 | b55de812043b670cbde810d7d42f45909b6d66ef | |
| ToppCell | COVID-19-lung-Ciliated|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.76e-05 | 189 | 100 | 5 | a2da5debd10f27b1280b40141ef0bfef007cc72c | |
| ToppCell | droplet-Lung-1m-Epithelial|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.76e-05 | 189 | 100 | 5 | 72ecd5a10e419bac475e22f5b602e7f008835ce9 | |
| ToppCell | droplet-Lung-3m-Epithelial-airway_epithelial|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.76e-05 | 189 | 100 | 5 | a28e0922e10013ae79266f6a3f9305e6ee614d8b | |
| ToppCell | PND07-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.76e-05 | 189 | 100 | 5 | 9f57a131902d23494bf389baf6e6e2d99f88b2c8 | |
| ToppCell | Adult-Epithelial-ciliated_cell|Adult / Lineage, Cell type, age group and donor | 6.76e-05 | 189 | 100 | 5 | b679920f0993e917dd86da082113bfbd85ea1ca5 | |
| ToppCell | COVID-19-lung-Ciliated|lung / Disease (COVID-19 only), tissue and cell type | 6.76e-05 | 189 | 100 | 5 | 27329c4661aebabd19fac7fe5dca263fe99d76f3 | |
| ToppCell | PND01-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.76e-05 | 189 | 100 | 5 | 4e83e49d1265ffe507fdb72924c77c4d1c73f0bd | |
| ToppCell | PND07-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.76e-05 | 189 | 100 | 5 | e443b02502edaefa94567a9e8af5756e8e11ff30 | |
| ToppCell | facs-Lung-nan-3m-Epithelial-Ciliated_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.93e-05 | 190 | 100 | 5 | e243b5fbb17b9ec3cc90bbe970c1d30b0fd1c2e1 | |
| ToppCell | PND14-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.93e-05 | 190 | 100 | 5 | 088e3f39a1e5e11354d6e7458e8e6a39f14936b3 | |
| ToppCell | PND14-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.93e-05 | 190 | 100 | 5 | 35248a8be476ea8d06d67c3d98a25be1f7c150b7 | |
| ToppCell | droplet-Marrow-BM_(NON-STC)-30m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.93e-05 | 190 | 100 | 5 | 4288189e3a499c395896c950598810b02f401685 | |
| ToppCell | PND14-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated-Ciliated_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.93e-05 | 190 | 100 | 5 | 5f5206f9e725070d865f4c891ff08bb750e58582 | |
| ToppCell | facs-Lung-nan-3m-Epithelial-ciliated_columnar_cell_of_tracheobronchial_tree|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.93e-05 | 190 | 100 | 5 | fe844559b95832845d2e8d3ab4b57e3d558bc372 | |
| ToppCell | facs-Lung-3m-Epithelial-airway_epithelial-lung_ciliated_cell-ciliated_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.11e-05 | 191 | 100 | 5 | 649fcb62ad15de2f83e61591e43923a717664ae7 | |
| ToppCell | facs-Lung-3m-Epithelial-airway_epithelial-lung_ciliated_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.11e-05 | 191 | 100 | 5 | 9621e22e14ea069f22713947c9faa2d882abe5fe | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Ciliated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 7.11e-05 | 191 | 100 | 5 | 2a8e6d560907e71e9f6e190ca0667da804e25641 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Ciliated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.11e-05 | 191 | 100 | 5 | 46c9d4d10c66c0fae1fa351924091b69ea2f38d4 | |
| ToppCell | PND03-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.11e-05 | 191 | 100 | 5 | bda8faf92495c8b362850c0aff4fc6fbdd9c563b | |
| ToppCell | PND03-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated-Ciliated_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.11e-05 | 191 | 100 | 5 | 6880fb348bb0915db9a5da4f3566ca9ff93ed258 | |
| ToppCell | Mild_COVID-19-Epithelial-Ciliated|Mild_COVID-19 / Disease group,lineage and cell class （2021.01.30） | 7.11e-05 | 191 | 100 | 5 | 995e76bbf07674d95b8ef09e078cf6410af27a09 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Ciliated|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.11e-05 | 191 | 100 | 5 | a37f20172b85566b9039254a89680e37fd503fd5 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Ciliated|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 7.11e-05 | 191 | 100 | 5 | 2d36e08c5629cf73b6dd02cd173cafb52e8a3a7d | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial-MUC16+_ciliated|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 7.11e-05 | 191 | 100 | 5 | e81cd65dbf0ef1c2ab7088f73ce605d456dd3a7a | |
| ToppCell | facs-Lung-3m-Epithelial-airway_epithelial|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.11e-05 | 191 | 100 | 5 | 6a8fc9dc1a4c7115862e8f20204fa2f95e50e22f | |
| ToppCell | human_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 7.28e-05 | 192 | 100 | 5 | 916fbec1c7ab7969bda711886ac88e877e30c280 | |
| ToppCell | PND03-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.28e-05 | 192 | 100 | 5 | b5cdc2dae3154b1e4ade88f841f38584402ffe33 | |
| ToppCell | H1299-infected|H1299 / Cell line, Condition and Strain | 7.28e-05 | 192 | 100 | 5 | 9cf8049bdc3e0f81ce69042beac72b08d8f38b4e | |
| ToppCell | ASK428-Epithelial-Ciliated|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 7.28e-05 | 192 | 100 | 5 | 356ebddd03aec341b79890977edb8ff0804999a1 | |
| ToppCell | PND03-Epithelial-Epithelial_Airway|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.28e-05 | 192 | 100 | 5 | 2d8d5a38e205339eda9c8aca1ca9ba3dcbe5ae56 | |
| ToppCell | human_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells) | 7.46e-05 | 193 | 100 | 5 | e6a688bc834f845ff64dae1be64f073eec5091a1 | |
| ToppCell | wk_20-22-Epithelial-Proximal_epithelial-MUC16+_ciliated|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 7.65e-05 | 194 | 100 | 5 | 756082a0f5953b52229bb60d40b84701cb6cb23d | |
| ToppCell | 11.5-Distal-Mesenchymal-Pericyte|Distal / Age, Tissue, Lineage and Cell class | 7.65e-05 | 194 | 100 | 5 | 08701590496cf85ff790e54a81493c61177e76ff | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.65e-05 | 194 | 100 | 5 | 4a2c127c90d1fefe604fcb9e796577d21b489dd6 | |
| ToppCell | COVID-19-Heart-CM_1|Heart / Disease (COVID-19 only), tissue and cell type | 7.83e-05 | 195 | 100 | 5 | f1ef50331eda8f1239dba6ea970df4eaccf032f1 | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial-Ciliated|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 7.83e-05 | 195 | 100 | 5 | cfcf554b436083179dea1d6fd6e3a800ea2430fe | |
| ToppCell | COVID-19-Heart-CM_2|Heart / Disease (COVID-19 only), tissue and cell type | 7.83e-05 | 195 | 100 | 5 | 75fc81bddb246dca3b437fb60827b1d4fe416405 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.83e-05 | 195 | 100 | 5 | 79dc031258579ea328181dda33710dd897f1064a | |
| ToppCell | severe-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 8.22e-05 | 197 | 100 | 5 | 57ebd552f10d6278623b52a3d484d4b91ae1d028 | |
| ToppCell | droplet-Marrow-nan-18m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.42e-05 | 198 | 100 | 5 | 54da18209ad67bf6b6b984786d95962fa90e6e8d | |
| ToppCell | wk_08-11-Mesenchymal-Myofibro_&_SMC-Pericyte|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 8.42e-05 | 198 | 100 | 5 | 72aad5b2dcd8b0bde58828fa4f8129fe6cb6a21d | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Layer_IV-2|World / Primary Cells by Cluster | 8.62e-05 | 199 | 100 | 5 | f09b40245d3d826275bbe5f508dedccc75a911bd | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Layer_IV|World / Primary Cells by Cluster | 8.62e-05 | 199 | 100 | 5 | e45448ec4db8875c8aaa9aad109a10e2905a4226 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_ciliated|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.62e-05 | 199 | 100 | 5 | 2498237b9e895ca4826a3378d9d40989968df72b | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_ciliated-Ciliated|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.62e-05 | 199 | 100 | 5 | 542ec45c931b40738df1f3777b00c83be33a514a | |
| ToppCell | (01)_IL1RL1+-(2)_GFP_FOXI1|(01)_IL1RL1+ / shred by cell type by condition | 8.62e-05 | 199 | 100 | 5 | a2f7d0cabf35b80fe239fae34a77bf9344d5d743 | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_airway_ciliated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 8.83e-05 | 200 | 100 | 5 | 52aef65f01b06cd98056f17977efe525aee6eb6f | |
| Drug | NSC366363 | 7.97e-08 | 3 | 99 | 3 | CID000339501 | |
| Drug | AC1NDS53 | 7.97e-08 | 3 | 99 | 3 | CID004630710 | |
| Drug | tatsiensine | 7.97e-08 | 3 | 99 | 3 | CID000163526 | |
| Drug | delcosine | 7.97e-08 | 3 | 99 | 3 | CID000120726 | |
| Drug | purealin | 1.95e-07 | 58 | 99 | 6 | CID006419303 | |
| Drug | daurisoline | 2.33e-07 | 13 | 99 | 4 | CID000051106 | |
| Drug | thiomethylpromazine | 3.18e-07 | 4 | 99 | 3 | CID000070583 | |
| Drug | KS-504e | 3.18e-07 | 4 | 99 | 3 | CID000129559 | |
| Drug | KS-504d | 3.18e-07 | 4 | 99 | 3 | CID000129557 | |
| Drug | Archanagelicine | 3.18e-07 | 4 | 99 | 3 | CID003083773 | |
| Drug | Nsc642900 | 3.18e-07 | 4 | 99 | 3 | CID000498959 | |
| Drug | CTK0F9956 | 3.18e-07 | 4 | 99 | 3 | CID011779542 | |
| Drug | N,N-dimethyladriamycin-14-valerate | 3.18e-07 | 4 | 99 | 3 | CID000127194 | |
| Drug | 85318-25-8 | 3.18e-07 | 4 | 99 | 3 | CID006439702 | |
| Drug | cloxacepride | 3.18e-07 | 4 | 99 | 3 | CID000068859 | |
| Drug | Roylin | 3.18e-07 | 4 | 99 | 3 | CID000099924 | |
| Drug | chloraniformethan | 3.18e-07 | 4 | 99 | 3 | CID000030331 | |
| Drug | KS-502 | 3.18e-07 | 4 | 99 | 3 | CID000129242 | |
| Drug | KS-501 | 3.18e-07 | 4 | 99 | 3 | CID000129240 | |
| Drug | 2'-methoxykobusin | 3.18e-07 | 4 | 99 | 3 | CID000637889 | |
| Drug | Ti 233 | 3.18e-07 | 4 | 99 | 3 | CID000173248 | |
| Drug | diisopropylphosphoramidite | 3.18e-07 | 4 | 99 | 3 | CID000080867 | |
| Drug | PS-990 | 3.18e-07 | 4 | 99 | 3 | CID000157810 | |
| Drug | herbarumin III | 3.18e-07 | 4 | 99 | 3 | CID000643678 | |
| Drug | 2c5o | 4.56e-07 | 284 | 99 | 10 | CID000447956 | |
| Drug | jujubogenin | 7.92e-07 | 5 | 99 | 3 | CID005318721 | |
| Drug | D 890 | 7.92e-07 | 5 | 99 | 3 | CID000134083 | |
| Drug | 4H-1,4-benzothiazin-3-one | 7.92e-07 | 5 | 99 | 3 | CID000021396 | |
| Drug | Y-acid | 7.92e-07 | 5 | 99 | 3 | CID000007022 | |
| Drug | NSC-36360 | 7.92e-07 | 5 | 99 | 3 | CID000133340 | |
| Drug | C16AA | 7.92e-07 | 5 | 99 | 3 | CID000488017 | |
| Drug | auranthine | 7.92e-07 | 5 | 99 | 3 | CID000130919 | |
| Drug | alpha-CAO | 7.92e-07 | 5 | 99 | 3 | CID000196600 | |
| Drug | AC1NS8P3 | 7.92e-07 | 5 | 99 | 3 | CID005356151 | |
| Drug | Ant-ATP | 7.92e-07 | 5 | 99 | 3 | CID000134953 | |
| Drug | Nor2 chlorpromazine | 7.92e-07 | 5 | 99 | 3 | CID000074981 | |
| Drug | Fsh-beta-(1-15) | 7.92e-07 | 5 | 99 | 3 | CID005748474 | |
| Drug | Ac-dvda | 7.92e-07 | 5 | 99 | 3 | CID000146768 | |
| Drug | VUF 4576 | 7.92e-07 | 5 | 99 | 3 | CID000132784 | |
| Drug | 2,5-diketocamphane | 1.58e-06 | 6 | 99 | 3 | CID000020218 | |
| Drug | AC1NSV6X | 1.58e-06 | 6 | 99 | 3 | CID005317173 | |
| Drug | benziodarone | 1.58e-06 | 6 | 99 | 3 | CID000006237 | |
| Drug | AC1LCMSV | 1.58e-06 | 6 | 99 | 3 | CID000633347 | |
| Drug | CI-922 | 1.58e-06 | 6 | 99 | 3 | CID000146938 | |
| Drug | caged PE | 1.58e-06 | 6 | 99 | 3 | CID000192405 | |
| Drug | N-(8-aminooctyl)-5-iodonaphthalene-1-sulfonamide | 1.58e-06 | 6 | 99 | 3 | CID000004307 | |
| Drug | propyl-methylenedioxyindene | 1.58e-06 | 6 | 99 | 3 | CID000145934 | |
| Drug | 1-(4-pyridyl)ethanol | 2.76e-06 | 7 | 99 | 3 | CID000090919 | |
| Drug | MS-857 | 2.76e-06 | 7 | 99 | 3 | CID000129517 | |
| Drug | SQ 65442 | 2.76e-06 | 7 | 99 | 3 | CID000128039 | |
| Drug | AC1L3PE4 | 2.76e-06 | 7 | 99 | 3 | CID000093048 | |
| Drug | AC1L52O2 | 2.76e-06 | 7 | 99 | 3 | CID000196983 | |
| Drug | O-4-(ethoxybutyl)berbamine | 2.76e-06 | 7 | 99 | 3 | CID000188375 | |
| Drug | chloronitromethane | 2.76e-06 | 7 | 99 | 3 | CID000074529 | |
| Drug | trifluoperazine sulfoxide | 2.76e-06 | 7 | 99 | 3 | CID000159622 | |
| Drug | TZC-5665 | 2.76e-06 | 7 | 99 | 3 | CID006449836 | |
| Drug | KHL-8430 | 2.76e-06 | 7 | 99 | 3 | CID000195711 | |
| Drug | CPU57 | 2.76e-06 | 7 | 99 | 3 | CID000195730 | |
| Drug | DyCl3 | 2.76e-06 | 7 | 99 | 3 | CID000066207 | |
| Drug | Drnflrfamide | 2.76e-06 | 7 | 99 | 3 | CID000132879 | |
| Drug | 4-hydroxyphenylglycol | 2.76e-06 | 7 | 99 | 3 | CID003081980 | |
| Drug | DAPpNP | 2.76e-06 | 7 | 99 | 3 | CID005492375 | |
| Drug | T 7188 | 2.76e-06 | 7 | 99 | 3 | CID000003311 | |
| Drug | asocainol | 2.76e-06 | 7 | 99 | 3 | CID000071161 | |
| Drug | 3,7,8-trihydroxy-CPZ | 4.40e-06 | 8 | 99 | 3 | CID000467415 | |
| Drug | proxyl nitroxide | 4.40e-06 | 8 | 99 | 3 | CID000076702 | |
| Drug | niludipine | 4.40e-06 | 8 | 99 | 3 | CID000089767 | |
| Drug | KS-504a | 4.40e-06 | 8 | 99 | 3 | CID000129577 | |
| Drug | NSP-805 | 4.40e-06 | 8 | 99 | 3 | CID000130349 | |
| Drug | Ro 22-4839 | 4.40e-06 | 8 | 99 | 3 | CID000065839 | |
| Drug | HT-74 | 4.40e-06 | 8 | 99 | 3 | CID000126681 | |
| Drug | 2,6-ANS | 4.40e-06 | 8 | 99 | 3 | CID002762570 | |
| Drug | AC1MJ4D0 | 4.40e-06 | 8 | 99 | 3 | CID003085362 | |
| Drug | AC1L1E3K | 4.50e-06 | 56 | 99 | 5 | CID000002625 | |
| Drug | w66 | 6.57e-06 | 9 | 99 | 3 | CID006439460 | |
| Drug | 7,8-diOH-CPZ | 6.57e-06 | 9 | 99 | 3 | CID000159916 | |
| Drug | picumast | 6.57e-06 | 9 | 99 | 3 | CID000431850 | |
| Drug | 5-exo-hydroxycamphor | 6.57e-06 | 9 | 99 | 3 | CID000440017 | |
| Drug | adamantanone | 6.57e-06 | 9 | 99 | 3 | CID000064151 | |
| Drug | KS-505a | 6.57e-06 | 9 | 99 | 3 | CID003081782 | |
| Drug | C37H40N2O6 | 7.35e-06 | 29 | 99 | 4 | CID000010170 | |
| Drug | EGTA-AM | 7.46e-06 | 62 | 99 | 5 | CID000121907 | |
| Drug | 1-isoamyl-3-isobutylxanthine | 9.36e-06 | 10 | 99 | 3 | CID000152034 | |
| Drug | norchlorpromazine | 9.36e-06 | 10 | 99 | 3 | CID000062875 | |
| Drug | Kr I | 9.36e-06 | 10 | 99 | 3 | CID005288675 | |
| Drug | AC1L8MM4 | 9.36e-06 | 10 | 99 | 3 | CID000429016 | |
| Drug | verapamil | CACNA1B ABCF1 CALM1 CALM2 CALM3 MYH7B MYO18A ABCC9 KCNG1 ABCB11 KCNS3 | 9.40e-06 | 490 | 99 | 11 | CID000002520 |
| Drug | mexiletine | 1.02e-05 | 66 | 99 | 5 | CID000004178 | |
| Drug | Ins(1,3)P2 | 1.28e-05 | 11 | 99 | 3 | CID000128419 | |
| Drug | indolidan | 1.28e-05 | 11 | 99 | 3 | CID005284402 | |
| Drug | 1-(5-aminopentyl)-3-phenylthiourea | 1.28e-05 | 11 | 99 | 3 | CID003035524 | |
| Drug | 4-iodotamoxifen | 1.28e-05 | 11 | 99 | 3 | CID003037006 | |
| Drug | alpha-amyrin linoleate | 1.28e-05 | 11 | 99 | 3 | CID005318324 | |
| Drug | IQ-3 | 1.28e-05 | 11 | 99 | 3 | CID000028212 | |
| Drug | AC1Q5XN5 | 1.28e-05 | 11 | 99 | 3 | CID000190946 | |
| Drug | AC1L2NX7 | 1.28e-05 | 11 | 99 | 3 | CID000125056 | |
| Drug | rubrofusarin | 1.28e-05 | 11 | 99 | 3 | CID000072537 | |
| Drug | CV-159 | 1.71e-05 | 12 | 99 | 3 | CID000135211 | |
| Drug | NSC234486 | 1.71e-05 | 12 | 99 | 3 | CID000002674 | |
| Drug | AC1O3Q5W | 1.71e-05 | 12 | 99 | 3 | CID006334250 | |
| Disease | VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1 (disorder) | 1.91e-08 | 10 | 93 | 4 | C1631597 | |
| Disease | Romano-Ward Syndrome | 1.65e-05 | 16 | 93 | 3 | C0035828 | |
| Disease | Brugada Syndrome (disorder) | 5.85e-05 | 24 | 93 | 3 | C1142166 | |
| Disease | Global developmental delay | 6.52e-05 | 133 | 93 | 5 | C0557874 | |
| Disease | lumbar disc degeneration | 9.38e-05 | 28 | 93 | 3 | EFO_0004994 | |
| Disease | Kartagener Syndrome | 1.84e-04 | 35 | 93 | 3 | C0022521 | |
| Disease | Polynesian Bronchiectasis | 1.84e-04 | 35 | 93 | 3 | C4317124 | |
| Disease | Ciliary Dyskinesia, Primary, 1, With Or Without Situs Inversus | 1.84e-04 | 35 | 93 | 3 | C4551906 | |
| Disease | Primary ciliary dyskinesia | 2.01e-04 | 36 | 93 | 3 | cv:C0008780 | |
| Disease | Phencyclidine-Related Disorders | 2.04e-04 | 7 | 93 | 2 | C0236742 | |
| Disease | Phencyclidine Abuse | 2.04e-04 | 7 | 93 | 2 | C0031391 | |
| Disease | Cannabis Abuse | 4.35e-04 | 10 | 93 | 2 | C0006868 | |
| Disease | Cannabis-Related Disorder | 4.35e-04 | 10 | 93 | 2 | C0236735 | |
| Disease | Hashish Abuse | 4.35e-04 | 10 | 93 | 2 | C0018614 | |
| Disease | Primary Ciliary Dyskinesia | 4.44e-04 | 47 | 93 | 3 | C4551720 | |
| Disease | Dental enamel hypoplasia | 6.35e-04 | 12 | 93 | 2 | EFO_1001304 | |
| Disease | Yu-Zhi constitution type | 1.00e-03 | 15 | 93 | 2 | EFO_0007638 | |
| Disease | ascending aortic diameter | 1.02e-03 | 140 | 93 | 4 | EFO_0021787 | |
| Disease | stroke | 1.13e-03 | 144 | 93 | 4 | EFO_0000712 | |
| Disease | Cannabis Dependence | 1.30e-03 | 17 | 93 | 2 | C0006870 | |
| Disease | cancer (implicated_via_orthology) | 1.61e-03 | 268 | 93 | 5 | DOID:162 (implicated_via_orthology) | |
| Disease | hydrocephalus (implicated_via_orthology) | 1.62e-03 | 19 | 93 | 2 | DOID:10908 (implicated_via_orthology) | |
| Disease | Atrial Fibrillation | 1.67e-03 | 160 | 93 | 4 | C0004238 | |
| Disease | airway responsiveness measurement | 2.59e-03 | 24 | 93 | 2 | EFO_0006897 | |
| Disease | Back pain | 2.65e-03 | 87 | 93 | 3 | HP_0003418 | |
| Disease | severe acute respiratory syndrome, COVID-19 | 2.94e-03 | 447 | 93 | 6 | EFO_0000694, MONDO_0100096 | |
| Disease | Intellectual Disability | 2.94e-03 | 447 | 93 | 6 | C3714756 | |
| Disease | response to norepinephrine-dopamine reuptake inhibitor | 3.04e-03 | 26 | 93 | 2 | EFO_0007870 | |
| Disease | osteoarthritis, hip | 3.11e-03 | 92 | 93 | 3 | EFO_1000786 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KDVDDDGEEKELMER | 86 | Q8NE71 | |
| DEMIVSDKEERTDAA | 2466 | A6H8Y1 | |
| KLTDEEVDEMIREAD | 116 | P0DP25 | |
| EEEDEMEVEDQDSKE | 26 | Q96SW2 | |
| EEDIKDATEDDMLAR | 666 | O95342 | |
| KEMEREAEENDLSEE | 886 | Q9P1A6 | |
| AKAQMEDEDEEEEEE | 946 | O60706 | |
| VDSSDEERMEETKEA | 96 | Q3SXY8 | |
| LMKEEIQDEEDDDDY | 221 | Q9BTT0 | |
| QEDDEFLMATDVDDR | 181 | Q12797 | |
| KLTDEEVDEMIREAD | 116 | P0DP24 | |
| EEVMLAEEDRNAEEK | 396 | Q00975 | |
| QELTKDEEEMEEAAN | 716 | Q00975 | |
| DLDFSEAMDLREDKD | 66 | P51861 | |
| REDKDFLEDMDSLED | 76 | P51861 | |
| EQKELDQDMVTEDED | 721 | Q9NRL2 | |
| VNEDVEEMEIDEQTK | 1031 | Q9NRL2 | |
| CESDQEKEEEEEMER | 216 | P53805 | |
| KEDINAIEMEEDKRD | 261 | P49756 | |
| KGREEEDMEEEENDD | 221 | Q9NW13 | |
| FETEADEKREMALEE | 681 | P49796 | |
| MVSRKEEDTAQAEEE | 1396 | Q4ADV7 | |
| QDLVDESEEERFDDM | 111 | Q6IN85 | |
| DGEERDDEMENKQDV | 186 | Q96JM7 | |
| EEEIDMTSEKNDETE | 1466 | Q01484 | |
| RNVLLQMEEEEDDDD | 6 | Q4KMQ2 | |
| DEEDQSLDDMEKISR | 781 | O60500 | |
| IEDTLMDTEEQEEFK | 5186 | Q9NU22 | |
| MDTEEQEEFKAADVE | 5191 | Q9NU22 | |
| EDEDEDNDDIVMLEK | 261 | Q86WA8 | |
| LDESDAEMELRAKEE | 111 | Q9P035 | |
| IFEMDDNDSQKEEEI | 281 | Q15742 | |
| ETDEDKMEEYKDELE | 71 | Q9HCE5 | |
| EDLDESDDDMDEKLQ | 696 | O43150 | |
| MQEEEEQRRKEEEEE | 766 | B1AK53 | |
| TIDEEAEMEEQAERD | 1346 | Q15751 | |
| EMIVEEEEEEENERK | 121 | Q53HL2 | |
| ELDDAEERADMAETQ | 1951 | A7E2Y1 | |
| DSEEDEKMEEDNKEE | 301 | Q96MG8 | |
| MEEETEVRESEKQQD | 366 | Q9H307 | |
| IEDEMESDENEDLIN | 1936 | Q92614 | |
| DEDEDDSLKDRELMV | 1331 | O94915 | |
| EEEDDMKIDEKCVEA | 336 | Q96JB8 | |
| DEDEEMKDLLDFADV | 851 | Q9UL01 | |
| CLDEDRQREEEEDKM | 801 | Q8N3F8 | |
| AVDTKEEESEDIENM | 271 | Q9BQ31 | |
| FAEMVEREEEDDALD | 176 | Q9UIX4 | |
| MVEEKESLDFDVEDI | 391 | Q9Y4A0 | |
| QDLIDESEEERFEEM | 111 | Q5MIZ7 | |
| MADDKVAILTDDEEE | 1 | Q6ZSS7 | |
| EEMETETEAEALQEK | 1086 | Q8IZL8 | |
| RERAEKEEAQSEMEA | 196 | Q96M63 | |
| LELAEQTEMEGEKEE | 586 | Q96MC2 | |
| EEEHRKALEEEEMEQ | 336 | O00461 | |
| EERKEEEEMQAEAEE | 1221 | Q92794 | |
| LRKMVDEDQEEEEDK | 106 | Q7Z7G2 | |
| NMDEEEYDALTEEEK | 2301 | Q4G0P3 | |
| EDDKASQRQFEMEEL | 76 | P31415 | |
| KTLAELDEDLEEMED | 491 | O75128 | |
| KEFSFMDEEEEDEIR | 341 | Q9H3Q1 | |
| KLAADCMRDVEEEEE | 81 | Q5T0F9 | |
| MAVDVDECKEREDEE | 136 | P48740 | |
| QKTEVEDADMLESEE | 461 | Q8NA03 | |
| KLTDEEVDEMIREAD | 116 | P0DP23 | |
| EEIERMVNDAEKFAE | 536 | P11021 | |
| ERSGEDEEQKEEAMV | 6 | Q6ZQY2 | |
| EKADMEENEEISSDE | 891 | O15397 | |
| SVDDNNEEEEDVEMK | 241 | A1Z1Q3 | |
| NEEEEDVEMKEDSDE | 246 | A1Z1Q3 | |
| IDKESDDVLERIMDE | 516 | Q15542 | |
| SDEDEKMDEESAQIE | 1796 | P46939 | |
| EKADAEENLEDAMEE | 236 | Q68DH5 | |
| DMDEIEKYQEVEEDQ | 1161 | Q6P3W6 | |
| MDEIEKYQEVEEDQD | 1406 | Q6P3W6 | |
| VDMDEIEKYQEVEED | 2136 | Q6P3W6 | |
| DMDEIEKYQEVEEDQ | 2381 | Q6P3W6 | |
| MDEIEKYQEVEEDQD | 2626 | Q6P3W6 | |
| VDMDEIEKYQEVEED | 3356 | Q6P3W6 | |
| DMDEIEKYQEVEEDQ | 3601 | Q6P3W6 | |
| VDMDEIEKYQEVEED | 576 | Q5TI25 | |
| VDMDEIEKYQEVEED | 651 | Q5TI25 | |
| IDMDEIEKYQEVEED | 401 | Q8N660 | |
| IDMDEIEKYQEVEED | 401 | A0A087WUL8 | |
| DMDEIEKYQEVEEDQ | 646 | A0A087WUL8 | |
| MDEIEKYQEVEEDQD | 891 | A0A087WUL8 | |
| VDMDEIEKYQEVEED | 1621 | A0A087WUL8 | |
| DMDEIEKYQEVEEDQ | 1866 | A0A087WUL8 | |
| MDEIEKYQEVEEDQD | 2111 | A0A087WUL8 | |
| VDMDEIEKYQEVEED | 2841 | A0A087WUL8 | |
| DMDEIEKYQEVEEDQ | 3086 | A0A087WUL8 | |
| MDEIEKYQEVEEDQD | 3331 | A0A087WUL8 | |
| VDMDEIEKYQEVEED | 301 | P0DPF2 | |
| DMDEIEKYQEVEEDQ | 546 | P0DPF2 | |
| MDEIEKYQEVEEDQD | 791 | P0DPF2 | |
| VDMDEIEKYQEVEED | 1521 | P0DPF2 | |
| DMDEIEKYQEVEEDQ | 1766 | P0DPF2 | |
| MDEIEKYQEVEEDQD | 2011 | P0DPF2 | |
| VDMDEIEKYQEVEED | 2741 | P0DPF2 | |
| DMDEIEKYQEVEEDQ | 2986 | P0DPF2 | |
| MDEIEKYQEVEEDQD | 3231 | P0DPF2 | |
| VDMDEIEKYQEVEED | 3961 | P0DPF2 | |
| DMDEIEKYQEVEEDQ | 4206 | P0DPF2 | |
| EEDFQMKIDDEVRTA | 916 | P21675 | |
| RERMDEEQKLYTDDE | 216 | P13521 | |
| EEMFEEEAEEEVFLK | 66 | Q86XR7 | |
| EEENKKDDEEMDIDT | 76 | O95149 | |
| MEVQGEEEKREDKED | 311 | O75381 | |
| NEEDVEKEEETERML | 316 | Q9Y2L1 | |
| HREEEQEDLTKDMDE | 331 | Q8TAQ2 | |
| LLENDEKDEEDMSLD | 1496 | Q9UK61 | |
| AMEAAGEEEEEQRKE | 106 | Q7LGC8 | |
| MLKEEKREEDEENDN | 106 | Q9NRG0 | |
| VKKMSDDEDDDEEEY | 121 | Q7KZ85 | |
| LAMFEDDEIDEVKQE | 151 | O75486 | |
| EEEEVVDKMDDDVFL | 1271 | P24928 | |
| EEAEEEDEQDIMKVL | 661 | Q9H5I5 | |
| MEAEDLSKAEDRNED | 1 | Q6ZS81 | |
| KAEMSDLDDLEREIE | 251 | Q8IYM2 | |
| MHQKDREDQEEELED | 1731 | Q8IUG5 | |
| LQESLEAEEMDEETK | 126 | Q9HBF4 | |
| NTDEEDVVEEKMVAE | 36 | P86452 | |
| MEEEERGNFEKAEVE | 1821 | Q96JM2 | |
| DDEDKEEEMNSKAED | 2381 | Q96JM2 | |
| EKVEDMFNKDDEEDR | 676 | O15041 | |
| NAEDEEEEGTMKRRD | 371 | Q13043 | |
| NAMLDEDEDERVDEA | 181 | Q9BSL1 | |
| EDMGDEDKEERQESR | 351 | Q96RL1 | |
| STDDKEEMCRIEEEQ | 366 | Q5THJ4 | |
| DEDEEMDEVSLLSEL | 91 | Q9P2K6 | |
| EEEEEEDENKSAMLE | 51 | Q96M32 | |
| DSDEEEEMDTSERKI | 311 | Q9BWU0 |